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Background: It is important that NHS resources are used to their full extent, but efforts to reduce costs
may have an adverse effect on patient outcomes. Our research is designed to provide a better
understanding of the inter-relationship between costs and health outcomes among NHS providers
(hospitals) for common surgical procedures.
Objectives: In England, patient-reported outcomes measures (PROMs) are collected from patients
undergoing one of four elective procedures: unilateral hip replacement, unilateral knee replacement, groin
hernia repair and varicose vein surgery. We identify variation in patient-reported outcomes (PROs) across
hospitals, assess the relationship between the cost and outcomes among NHS hospitals for these
procedures, and determine the extent to which variations in outcomes and costs are due to differences in
hospital performance.
Data sources: We link Hospital Episode Statistics (HES) data with reference cost data and PROM data for
patients having the four treatments between April 2009 and March 2010.
Methods: The ﬁrst part of the empirical analysis focuses on variation in different dimensions of
self-reported health status. We argue that each of the EuroQol-5D questionnaire (EQ-5D; European Quality
of Life-5 Dimensions) dimensions should be assessed separately. Our graphical summary of the differential
impact that hospitals have on PROs indicates the probability of reporting a given health outcome and
shows how these probabilities vary across EQ–5D dimensions and hospitals. The second part of the
empirical analysis focuses on the performance of hospitals and the inter-relationship between PROs and
resource use.
Results: We ﬁnd that poorer post-treatment health status is associated with lower initial health status,
higher weighted Charlson score, more diagnoses and lower socioeconomic status. We ﬁnd signiﬁcantly
unexplained variation among hospitals in outcomes for patients undergoing hip replacement, knee
replacement or varicose vein surgery, but not for hernia patients. For all four treatments we ﬁnd signiﬁcant
unexplained variation in resource use among hospitals, whether measured by cost of treatment or length
of stay. This suggests that hospitals can improve their utilisation of resources.
Limitations: Our analyses are based on the HES. If data are missing from the medical record, or extracted
and coded inaccurately, HES will contain errors. Hospitals should minimise these errors. Our study suffers
from a large number of missing data, mainly because some hospitals were better than others at
administering the baseline survey.v
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ABSTRACT
viConclusions: There is no general evidence that hospitals with lower resource use have worse health
outcomes. There is a signiﬁcant positive correlation for varicose veins, but this is sensitive to the choice of
resource use and PRO measures. For hip and knee replacement the correlation is either insigniﬁcant or
negative (depending on the resource use and PRO measures), implying that promoting health outcomes
and controlling costs are not contradictory objectives. Indeed, we are able to identify hospitals with better
than expected outcomes where resource use is below average. Future research should address how to
handle missing data, evaluate hospital performance within the broader health economy, communicate
PROMs to prospective patients, evaluate the impact of PROMs on patient choice and provider behaviour
and evaluate PROMs for people with chronic conditions.
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The economic downturn makes it even more important that NHS resources are used to their full extent.
There is a danger that efforts to reduce costs have an adverse effect on patient outcomes. Our research is
designed to provide a better understanding of the inter-relationship between costs and health outcomes
among NHS providers (hospitals) for common surgical procedures.
We examine the relationship between the cost of hospital care with the associated improvement in
patient-reported outcome measures (PROMs) as measured both by a generic instrument, the EuroQol-5D
questionnaire (EQ-5D; European Quality of Life-5 Dimensions), and a condition-speciﬁc instrument for each
of four surgical procedures: unilateral hip replacement, unilateral knee replacement, groin hernia repair
and varicose vein surgery. The analysis includes measures of the variability in outcomes and resources
across hospitals, and considers the sensitivity of the results to choices of outcome instrument and measure
of resource use.Objectives
The overall aims are (1) to characterise variation in outcomes in ways that are intuitive to patients and
consistent with the original format of the questionnaire, thereby helping patients select a preferred
provider of care and (2) to assess the relationship between the cost and outcomes of the four elective
procedures for which the PROM data are collected to determine the extent to which variations in outcome
and cost ratios are due to differences in hospital performance. In meeting these aims we consider:
l which instrument should be used to measure patient-reported outcomes (PROs)
l the extent to which variations in outcomes and cost of treatment are due to patient characteristics
l the relationship between outcomes and cost of treatment
l the inﬂuence of the hospital on outcomes and cost of treatment
l how robust these estimates of hospital inﬂuences are to choices about how to conduct the analyses.
Two distinct pieces of work address these aims. The ﬁrst part of the empirical analysis focuses on
econometric techniques to analyse variation in different dimensions of patient self-reported health status.
This is designed to provide feedback to patients in a format consistent with their questionnaire responses
and to help them select their preferred hospital. The second part of the empirical analysis focuses on the
performance of hospitals in terms of the inter-relationship between PROs and resource use. The primary
audiences for this analysis are the Department of Health, hospitals and commissioners interested in
performance measurement.Data sources and methods
We link Hospital Episode Statistics (HES) data with reference cost data, and the PROs taken prior to
treatment and either 3 months or 6 months after treatment for patients having one of the four treatments
between April 2009 and March 2010.
Initially, we analyse data for 27,133 patients undergoing hip replacement in 154 hospitals. We estimate
hierarchical ordered probit models separately for each of the EQ-5D dimensions and compare results with
those obtained from a linear regression of the EQ-5D utility scores. We control for various patientxv
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SCIENTIFIC SUMMARY
xvicharacteristics (as risk adjustment), including pretreatment health status and recognise that patients are
clustered within hospitals.
For the second part, we analyse 48,008 patients having one of the four procedures. We use
random-effects hierarchical models that control for patient characteristics and identify the inﬂuence of
each hospital on outcomes and resource use. To explore the inter-relationship between outcomes and
resource use, we adopt a seemingly unrelated regression framework. We assess the sensitivity of results to
the choice of generic or condition-speciﬁc measures of PROs and to whether resource use is measured
using cost of treatment or length of stay (LoS).Results
In the ﬁrst study, we ﬁnd that:
l With regard to risk adjustment, poorer post-treatment health status for individual patients is related to
lower pretreatment health status, higher weighted Charlson score, a greater number of diagnoses and
greater deprivation in the neighbourhood of residence.
l Variability in the impact that hospitals have on post-treatment health status is most pronounced on the
EQ-5D dimensions mobility and usual activities, and less so for other dimensions.
l Only pain/discomfort and anxiety/depression correlate well with performance measures based on the
EQ-5D utility index. This leads to different assessments of hospital performance across metrics. Hence,
analysing EQ-5D dimensions provides different insights than the analysis of the EQ-5D index.
In the second study we ﬁnd that:
l Poorer post-treatment health status for individual patients is related to lower pretreatment health
status, higher weighted Charlson score, a greater number of diagnoses and greater deprivation in the
neighbourhood of residence. The inﬂuence of age and gender on the health status of patients varies
by procedure.
l Healthcare Resource Groups are signiﬁcantly explanatory for variation in resource use among patients.
The signiﬁcance of other variables varies according to the procedure and to whether resource use is
measured by cost of treatment or LoS.
l After controlling for patient characteristics, we ﬁnd substantial unexplained variation among hospitals
in the post-treatment health status of patients having either hip or knee replacement.
l In contrast, there is no substantial unexplained variation among hospitals in post-treatment health
status for patients having groin hernia repair, rendering the information redundant for benchmarking
hospital performance for these patients. Hence, we do not jointly analyse resource use and
post-treatment health status for these patients.
l For varicose veins, variation across hospitals in post-treatment health status is evident if using the
condition-speciﬁc, but not the generic, PROMs.
l We also ﬁnd that, for all four procedures, there is signiﬁcant unexplained variation in resource use
among hospitals, whether this is measured by cost of treatment or LoS. These results suggest room for
improvement among hospitals with regard to their utilisation of resources.
l At the patient level, we ﬁnd a negative correlation between risk-adjusted resource use and
post-treatment health status for patients having hip or knee replacement. With regard to varicose
veins, this relationship was not signiﬁcant.
l There is no general evidence at hospital level that reducing resource use has an adverse effect on
health outcomes. There is a signiﬁcant correlation for varicose veins, but this is sensitive to the choice
of resource use and PRO measures. For knee replacement there is no correlation and for hip
replacement the correlation is negative (though weakly signiﬁcant), implying that promoting health
outcomes and controlling costs are not contradictory objectives.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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patients who also have lower than average levels of resource utilisation.Limitations
Our analyses are based on routinely available secondary data, notably the information recorded in the HES,
the accuracy of which may be questioned. However, hospitals are mandated to provide HES data for all
patients, coding guidelines have been developed over many years and various forms of quality control are
implemented. The HES data derive originally from the medical record, so if data are inaccurate or missing
in the medical record, or if the hospital fails to extract and code these data accurately, errors will arise. We
believe that it is the responsibility of hospitals and their staff to minimise these errors.
Our study suffers from a high number of missing data, mainly because some hospitals were better than
others at administering the baseline survey. Participation by hospitals has since improved. Even so, future
research needs to consider how best to handle missing data for performance evaluation.Conclusions
We argue that, instead of focusing on the EQ-5D utility scores, it is more appropriate statistically, and
more informative, to assess each of the EQ-5D dimensions in its own right. Our approach does not require
assumptions to be made regarding how to aggregate across health dimensions and offers insight
regarding which dimensions are particularly affected by hospital heterogeneity.
In recognition of the expectation that PROMs data are to be widely used, we have suggested an intuitively
appealing way of summarising the differential impact that hospitals have on PROs. Our graphical
representation indicates the probability of reporting a given health outcome and shows how these
probabilities vary across health dimensions and hospitals. We argue that this information should be of
value in helping prospective patients choose which hospital they wish to provide their treatment.
We ﬁnd signiﬁcant variation among hospitals in both the post-treatment health status experienced by their
patients and their resource use. This variation persists after controlling for a wide range of patient
characteristics and is generally robust to the choice of instrument used to measure PRO and to whether
resource use is measured by cost of treatment or LoS. This variation suggests improved performance
among hospitals is possible both in promoting health outcomes and controlling costs. For hip replacement
and knee replacement, these objectives do not appear to be subject to trade-off, as we found no positive
correlation between outcomes and resource use after controlling for patient characteristics. Indeed, a few
hospitals were able to deliver superior outcomes despite utilising fewer resources. We believe regulators,
hospitals and commissioners should evaluate both outcome and resource use information in this fashion to
draw robust conclusions about relative hospital performance.
Future research should focus on improving methods to deal with missing data, collecting richer data to
characterise patient severity, evaluating hospital performance in the context of the broader health
economy, incorporating PROMs in the broader quality assurance framework, investigating means of
communicating information regarding variations in hospital PROM performance to patients, evaluating the
impact of the PROMs initiative on patient choice and provider behaviour, and measuring and evaluating
PROMs for chronic conditions.Funding
The National Institute for Health Research Health Service and Delivery Research programme.xvii
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Patient-reported outcome measures (PROMs) are instruments that capture the patient’s own assessmentof his or her health.1 By comparing these measures of health through time – for example, before and
after treatment – changes in health can be identiﬁed and used to better understand the effect of health
care. PROMs are already widely used for making some health-care decisions – for example, the National
Institute for Health and Care Excellence (NICE) uses PROMs data to help establish the cost-effectiveness
of health-care technologies. However, relatively little is known about the clinical effectiveness and
cost-effectiveness of many services provided by the NHS in England in terms of their impact on
patient-reported health.
Since April 2009, all providers of publicly funded inpatient care in the English NHS have been required to
collect both generic and condition-speciﬁc instruments for four elective procedures: unilateral hip
replacement, unilateral knee replacement, varicose vein surgery and groin hernia repairs.2 Patients having
these procedures are invited to report their health status before surgery, as well as 3 or 6 months
after surgery.
The PROMs programme is unique internationally: the English NHS is the ﬁrst health-care system in the
world to require the routine collection of data on patient-reported health and the intention is to use these
data to inform a wide range of NHS decisions. Clinical teams may use these data to monitor their own
performance and to identify opportunities for improving the quality of services. Patients and their general
practitioners may use the information to choose which hospital to attend for treatment. Commissioners of
health-care services may use these data to establish which services, for which subgroups of patients, are
most effective and best value for money.
One of the most important catalysts for the introduction of the PROMs programme was the aim of using
these data to compare hospital performance. The changes in patients’ health status can be analysed to
identify systematic variation across hospital providers and are expected to ‘provide an indication of the
outcomes or quality of care delivered to NHS patients’.2 The identiﬁcation of which hospitals are most
successful in improving patient health makes it possible to link rewards to that performance either
indirectly, by patients choosing high-performing hospitals over poor performers, or directly by linking
performance-related payments to achievements in terms of PROMs. Both are seen as having the potential
to sharpen hospital incentives to improve quality. However, there are clearly risks associated with the use
of PROMs in this context. First, different instruments for measuring patient-reported outcomes (PROs) are
available. Results may be sensitive to the choice of instrument and patients may differ in what weight they
attach to the different dimensions used to describe health status. Second, variations in PROMs
performance across hospitals may relate to variations in resource use and costs. A better understanding of
the inter-relationship between costs and health outcomes is even more important in times of economic
constraint, when there is greater pressure to ensure that NHS resources are used to their full extent. If this
inter-relationship is poorly understood, there is a danger that efforts to reduce costs may have an adverse
effect on patient outcomes.
The overall aims of this project are to develop means to understand variation in outcomes and costs across
hospitals in the English NHS. More speciﬁcally, we aim to (1) characterise variation in outcomes in ways
that are intuitive to patients and consistent with the original format of the questionnaire, thereby helping
them select a preferred provider of care and (2) assess the relationship between the cost and outcomes of
the four elective procedures for which PROM data are collected and to determine the extent to which
variations in outcome and cost ratios are due to differences in hospital performance. In meeting these aims
we consider:
l which PROMs instrument should be used to measure outcomes
l the extent to which variations in outcomes and cost of treatment are due to patient characteristics1
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2l the relationship between outcomes and cost of treatment
l the inﬂuence of the hospital on outcomes and cost of treatment
l how robust these estimates of hospital inﬂuences are to choices about how to conduct the analyses.
The research we have conducted led to two distinct pieces of work that address different aspects of these
aims. The ﬁrst part of the empirical analysis focuses on econometric techniques to analyse variation in
different dimensions of patient self-reported health status, e.g. limitations in mobility or self-care, or the
level of pain/discomfort or anxiety experienced. The results of this analysis highlight variability in the impact
that hospital providers have on different dimensions of health, and we make suggestions on how best to
communicate such variability to patients and other non-technical audiences. Because this analysis is directly
aimed at developing methods for hospital comparison when the aim is to inform patient choice, we do
not consider treatment costs or hospital production constraints in our analysis. The second part of the
empirical analysis focuses on the performance of hospitals in terms of the inter-relationship between
patient-reported outcomes and resource use. These results are more relevant for commissioners of services
and hospital providers than for patients in the English NHS, where the costs of care are not linked to any
out-of-pocket payments.
The report is structured as follows. In Chapter 2 we sketch a conceptual framework that outlines the
inﬂuences on patient outcomes, notably patient characteristics and the hospital in which they are treated;
how to characterise outcomes; and the inter-relationship between outcomes and resource use. In
Chapter 3 we describe how we have linked data from various sources and how outcomes, resource use
and patient characteristics are measured. Chapter 4 is split into two parts according to the two broad
research questions and each part reports the econometric models, the sample and the results for each
question. We conclude with a discussion of the main insights from the project and some suggestions for
future reﬁnements should richer data capturing of individual characteristics become available.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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medical, surgical or preventative intervention. The underlying process can be considered as a production
function, where the patient’s initial pretreatment health status, H0, is transformed into a post-treatment
health status, H1. The difference between pre- and post-treatment health status is termed the health
outcome. An individual patient’s health outcome is a function (f) of several other factors, notably the
characteristics of the patient, X, and the quality, Q, of the treatment carried out, so that:
H1 ¼ fðH0, X , QÞ ð1Þ
For the elective procedures we study, treatment is provided in hospital. Hospitals combine ‘factors of
production’, including staff, equipment and capital to produce treatment, the quality of which is partly
determined by the speciﬁc amounts and combination of the input factors. However, quality may also be
inﬂuenced by other constraining factors that impact on production, such as the size of the hospital, the
number of procedures performed and whether or not doctors have to balance delivery of care with
teaching commitments. Denoting the hospital’s effort to provide high-quality care as Eh and exogenous
production constraints as Z, quality can be expressed as:
Q ¼ qðEh, ZÞ ð2Þ
and combining both equations, we obtain
H1 ¼ fðH0, X , Eh, ZÞ ð3Þ
Similarly, the cost function can be deﬁned analogously as:
C ¼ cðH0, X , Ec, ZÞ ð4Þ
where C is the measure of resource use for the individual patient, H0 is the patient’s initial health status,
X is a vector of patient characteristics, Ec is effort exerted by the hospital to contain resource use and
Z denotes exogenous production constraints.
A hospital may not put as much effort into securing the level of quality that patients would like, nor into
managing resource use as much as the regulator would like, partly because efforts on both objectives are
costly;3 however, it is difﬁcult to prove this because effort is inherently difﬁcult to observe. A suggested
solution has been to undertake comparative analysis of hospital performance. By comparing hospitals
against each other, insight can be gained into the underlying production process, the constraints on this
process and the effort exerted by different hospitals.4,5 This requires the analyst to be able to draw a clear
distinction between variations caused by factors such as differing patient case mix and other factors,
notably effort.Using outcome measures to evaluate quality of careInformation about patients’ health before and after treatment can be used to inform the choice of
prospective patients and assess hospital performance with respect to the effort put into advancing quality.
Clinical measures, such as blood pressure or joint movement, describe patient health in physiological terms3
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4but do not capture other relevant aspects, particularly quality of life.6 Only the patients themselves can give
a full account of their perceived health and, therefore, patients are increasingly recognised by regulatory
bodies as the preferred source of information about the effectiveness of care.7,8 To reduce the level of
complexity and minimise cognitive burden, instruments to measure PRO often focus on a restricted
number of health dimensions. A patient’s overall health status, H, can then be characterised as a function
of these dimensions, Hd, so that
H ¼ hðH1, … , HdÞ ð5Þ
where d = 1, . . . , D is the health dimension considered and h is an aggregation function to be deﬁned.
For simplicity, we drop the index for time here, but it should be clear that the argument applies to both
pre- and post-treatment health status.
Means of aggregating health dimensions into an overall score are available for a wide range of different
instruments. The NHS Information Centre has developed a quality performance assessment methodology
that builds on aggregate health scores and is currently being applied to the PROM data.9 For the
EuroQol-5D questionnaire (EQ-5D; European Quality of Life-5 Dimensions), aggregation involves calculating
weighted EQ-5D utility scores, where the weights reﬂect the preferences of the general population in
England.10,11 Post-treatment utility scores are then regressed on the pretreatment scores and case-mix
controls to measure variation across hospitals in terms of the change in utilities that they achieve. The use
of aggregate scores facilitates statistical analysis and allows for direct ranking of hospitals; however, this
comes at a price. We identify four reasons why, for the purpose of informing patient choice and
facilitating best practice dissemination through publishing performance data, analysing disaggregated
outcome data may be preferable.
First, no aggregation function is neutral and observed variations in health outcomes may be driven by the
choice of function, not genuine variation in performance.12 In some circumstances, one may be willing to
accept the value judgement implied or explicitly expressed by the aggregation function. For example, the
convention of using the preferences of the general public to aggregate EQ-5D proﬁles has a clearly
articulated rationale in the context of cost-effectiveness analysis and decisions concerning the allocation of
taxpayer funding.13 However, it should be understood that measuring and valuing health are two
genuinely different activities. The use of aggregate outcome data to inform patient choice raises normative
concerns because it imposes a common valuation of health dimensions. In fact, reporting relative hospital
performance with respect to changes in the EQ-5D utility, for example, would be justiﬁed only if all
(prospective) patients were to share the same relative values; however, patients may be heterogeneous
with respect to their relative valuations of health dimension, or their relative valuations may differ from
those of the general public.14–15 If so, analysing variation on the level of health dimensions may be more
appropriate as it allows patients to apply their own values when interpreting performance data.
Second, the use of performance data derived from the EQ-5D utility scores may be limited by patients’
difﬁculties in interpreting these quantities. In a recent qualitative study, Hildon et al.16 interviewed patients
and clinicians about their views on different metrics of hospital PROM performance.16 The results suggest
that ‘for patients [. . .], unlike measures of height or weight, PRO [. . .] scores are unfamiliar and their
values have no immediate meaning. It’s therefore necessary to transform them into interpretable forms, or
indeed into experiences rather than metrics, to make them useful’. Furthermore, patients ‘could not
distinguish between the four [metrics], but liked a percentage or what was for them intuitive scaling’.16
By analysing hospital performance in terms of disaggregated outcome data, inferences about performance
can be made using the same metric in which these data have been collected.
Third, any form of aggregation causes loss of detail and information.17 Once constructed, an aggregated
measure cannot reveal information about the underlying components and the degree to which hospital
providers affect each of them. Certain hospitals may perform well on one dimension but fall short on
another. For example, the EQ-5D measures health-related quality of life in terms of limitations on theNIHR Journals Library www.journalslibrary.nihr.ac.uk
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may be good at improving the patient’s post-treatment mobility, but may fail to provide the necessary care
to alleviate the patient’s concerns about his or her health status and the security of the hip implant.
Detailed information on the performance on each dimension can help to identify the source of this
problem and foster improvement through learning from other hospitals’ best practice.17
Fourth, there are statistical concerns arising from the analysis of aggregate health status. For example,
most instruments used to measure PRO impose ordinal scales onto the health dimension under
consideration. The reported health status is the result of a censoring process in which patients classify their
continuous, underlying health to a limited set of ordered categories. The use of statistical methods that do
not acknowledge the ordinal nature of the responses may result in logical inconsistencies, where outcomes
are predicted that cannot possibly be derived from the questionnaire.18,19
The ﬁrst of our empirical analyses addresses these matters.The correlation between outcomes and costsHospitals pursue multiple objectives, and two of the most commonly noted, and perhaps competing,
objectives are the requirements to provide high-quality care and to keep treatment costs low. Assessing
the performance of organisations in this context of multiple objectives is complicated by the lack of
agreement on the relative importance of each objective and potential trade-offs between them.20 There is
a risk that, in analysing and assessing achievements in isolation, important trade-offs may be overlooked
and organisations may be unduly rewarded or punished. Hence, an analysis of quality performance
without consideration of resource use, and vice versa, will inevitably be partial. In recognition of this
possibility, the second of our empirical analyses is designed to explore explicitly the inter-relationship
between costs and PROs.
There is a large body of literature that analyses variation in the performance of hospitals either in terms of
their cost control or their pursuit of quality, and provides evidence of signiﬁcant variation.5,21 Fewer studies
have examined the empirical relationship between costs and quality of care.22–28 These studies shed light
on whether higher costs are, on average, associated with better quality of care and whether hospitals’
efforts to reduce costs may have adverse effects on quality. In each of these studies, the measures of
quality and costs are averaged across patients within each hospital, which precludes consideration of the
relationship between costs and quality for speciﬁc hospitals.
To explore the joint performance of each hospital with respect to resource use and patient-reported health
outcomes, we derive the empirical speciﬁcation of the two equations introduced in An agency model of
health-care provision. These now allow for the possibility of measurement error and unobserved patient
characteristics as captured by εc and εh in the cost and health equations:
C ¼ cðH0, X , Ec, ZÞ þ εc ð6Þ
H1 ¼ fðH0, X , Eh, ZÞ þ εh ð7Þ
Cost control and quality of care are likely to be correlated owing to common factors in both εk and Ek and
where k = c, h. The sign, strength and factor through which the correlation operates depends on the
speciﬁc circumstances. For example, a more severe patient may require more resources and beneﬁt less
from treatment (i.e. lower health outcome) than his or her healthier counterpart. If severity is not observed
and, hence, not captured as part of X, it will be included in εk, thereby creating a negative correlation
between the objectives. Conversely, the hospital’s actions, such as employing more experienced surgeons
or providing better post-treatment care, may lead to better health outcomes at the cost of higher resource
use. Here, the correlation is positive and operates through the effort terms Ek.5
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6Making inferences about hospital performances requires setting a benchmark to which individual
performance can be compared. When performance cannot be assessed against an absolute target, as is
the case for cost containment or health outcomes, the average level of effort,
_
Ek, forms a natural
benchmark and (Ejk –
_
Ek) = 0 is a test of hospital-speciﬁc performance, where j = 1, . . . , J denotes the
individual hospital. Joint performance in relation to both resource use and outcomes can then be
expressed for each hospital as a point in the two-dimensional performance space
ðEjc − EcÞ
ðEjh − EhÞ
ð8Þ
where the origin is formed by the standardised benchmark, i.e.
_
Ec =
_
Eh = 0. This expression is comparable in
nature with incremental cost-effectiveness ratios (ICERs), which are often calculated in cost-effectiveness
research and, as such, are amenable to similar presentational techniques and interpretations,
e.g. cost-effectiveness plane plots. The primary difference between ICERs, as calculated for the assessment
of the cost-effectiveness of new medical technologies, and our measures of performance is that our
comparator is the risk-adjusted benchmark, not another technology or placebo. Our two-dimensional
performance space is depicted in Figure 1.
Hospitals can be classiﬁed into four different groups according to their performance on these two
objectives: better or worse than expected performers on both objectives simultaneously, or better or worse
than expected performers on one objective, but not the other. Hospitals located in the north-east and
south-east quadrants of the plane are identiﬁed as better than expected (‘good’) performers in terms of
health outcomes, whereas those in the two western quadrants are seen as worse than expected (‘poor’)
performers with respect to this objective. The same principle applies to their resource use, where all
hospitals in the southern quadrants perform well, whereas those in the northern quadrants perform badly,
utilising more resources than expected. A hospital is identiﬁed as performing well on both objectives if it is
situated in the south-east quadrant and provides care using substantially fewer resources and achieves
higher health outcomes than expected given their case mix and production constraints. Hospitals located
in the north-west quadrant are considered to perform badly with respect to the two objectives as they
deliver poorer outcomes and utilise more resources than expected.
Our second set of empirical analyses focuses on these issues and is discussed below.NW quadrant
(Bad cost performance)
(Bad outcome performance)
NE quadrant
(Bad cost performance)
(Good outcome performance)
SE quadrant
(Good cost performance)
(Good outcome performance)
Health outcomes
R
es
o
u
rc
e 
u
se
M
o
re
Le
ss
HigherLower
SW quadrant
(Good cost performance)
(Bad outcome performance)
FIGURE 1 Characterising performance in the two-dimensional performance space.
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In order to perform our empirical analyses, our study combines data from the English Hospital EpisodeStatistics (HES) inpatient database with the PROMs survey and the reference cost (RC) databases for the
period April 2009 to March 2010. The HES database includes detailed information on all NHS-funded
inpatient care provided by public and independent sector hospitals in England. We extract data on all
elective patients, aged 15 years or over, who underwent unilateral hip or knee replacement, varicose vein
surgery or groin hernia repair. Each patient is deﬁned in terms of the duration of his or her hospital stay
(termed, in England, as an inpatient spell). One of the idiosyncrasies of the HES database is the recording
of inpatient activity at consultant level. When multiple consultants treat a patient, more than one Finished
Consultant Episode (FCE) is generated. This is typically the case when patients require multidisciplinary care
and are transferred between specialties within the same hospital. In order to record all relevant
information regarding admission, discharge or comorbidities and to keep in line with international
literature on hospital activity, we link all FCEs arising from admission to discharge to construct inpatient
spells.29 We retain only complete records for each patient, i.e. where all relevant information is recorded.
Duplicate observations are removed from the database according to the algorithm described in
Appendix 1.
Since 2009, patients having one of four common surgical procedures have been surveyed about their
health status before and after treatment. The four procedures are unilateral hip replacement, unilateral
knee replacement, varicose vein surgery and groin hernia repairs.2 All providers of publicly funded inpatient
care in the English NHS are required to offer the pretreatment survey to all their patients who pass as ﬁt to
have one of these procedures. There may be systematic differences among hospitals in how many of their
patients are surveyed, especially if hospitals differ in the process by which they offer and administer the
survey. Patients are surveyed again, either 3 or 6 months post surgery, depending on the procedure. This
post-treatment survey is administered at a national level by an organisation contracted by the Department
of Health. For individual patients, we link the PROM surveys to the HES data using the episode identiﬁer
epikey. This linkage allows us to take account of a range of patient characteristics when we analyse the
PROMs data and to assess whether patients who responded to the pre- and post-treatment PROM surveys
differ from those that did not respond.
Cost data are linked to the HES data based on the Healthcare Resource Group (HRG), to which the patient
has been allocated, the hospital and specialty identiﬁer, his or her admission type and his or her length
of stay (LoS). For more detailed information on how to link HES and cost data, see the study by
Laudicella et al. from 2010.30Health outcomesWe measure a patient’s health status before and after surgery using condition-speciﬁc PROMs as well as a
generic measure, the EQ-5D. Data are derived as part of the PROM survey, where all eligible patients
undergoing one of the four elective procedures are invited to participate.2 Table 1 provides an overview of
the PROMs that are collected as part of the national PROM programme. Patients that have consented to
participate are requested to complete the paper-based survey prior to surgery. These data are usually
collected during the last outpatient appointment preceding the surgery or on the day of admission. As
noted above, patients are then sent another questionnaire either 3 or 6 months post surgery via postal
mail. To ensure consistency with respect to the timing of measurements, while retaining as much
information as possible, we exclude all observations for which (1) the recorded time between the
pretreatment survey and admission exceeds 12 weeks, (2) the post-treatment period is either shorter than
20 weeks or longer than 1 year for hip replacement and knee replacement patients, and (3) the
post-treatment period is either shorter than 8 weeks or longer than 24 weeks for groin hernia and varicose
vein surgery patients.7
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TABLE 1 PROM instruments by procedure
Procedure
Condition-speciﬁc
PROM Generic PROM
Data collection time
(months post operation)
Knee replacement OKS EQ-5D (including EQ-VAS) 6
Hip replacement OHS EQ-5D (including EQ-VAS) 6
Varicose vein surgery AVVQ EQ-5D (including EQ-VAS) 3
Groin hernia repair – EQ-5D (including EQ-VAS) 3
AVVQ, Aberdeen Varicose Vein Questionnaire; EQ-VAS, EuroQoL visual analogue scale; OKS, Oxford knee score;
OHS, Oxford hip score.
DATA SOURCES
8The EQ-5D is a generic measure of health-related quality of life. It consists of two components: the EQ-5D
descriptive system and a visual analogue scale, the EQ-VAS. The EQ-5D descriptive system is a widely used
generic measure of health-related quality of life.10,31 It describes impairments in overall health through
self-assessed limitations on ﬁve dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/
depression. For each of the ﬁve dimensions, patients can indicate whether they have (1) no problems,
(2) some/moderate problems or (3) extreme problems (in the case of the pain/discomfort and anxiety/
depression), are unable to (self-care and usual activities) or are confined to bed (mobility). Responses on
each dimension are translated into numeric values ranging from 1 to 3. A patient’s health proﬁle can then
be described as a series of numerical values, e.g. 11221 representing a patient that has some problems
performing usual activities and experienced moderate pain/discomfort, but reports no problems regarding
any other health dimension.
The EQ-5D health proﬁle can be aggregated to an index score using a UK-speciﬁc set of weights that are
derived from the general public and reﬂect societal preferences.11 The resulting index scores range from
– 0.542 to 1, where 1 is deﬁned as perfect health and 0 is deﬁned as equivalent to being dead. Values
lower than 0 indicate health states that are considered worse than being dead.32 Following the discussion
in Chapter 2, we use data on the health proﬁle of the patient to analyse hospital impact on individual
dimensions of health and the EQ-5D utility index to assess hospital performance in terms of cost of
treatment and outcomes.
The EQ-5D is a two-part instrument that also contains a vertical EQ-VAS. The EQ-VAS can be used to elicit
the patient’s own valuation of his or her own global health status. This scale ranges from 0 (worst
imaginable health) to 100 (best imaginable health). Patients indicate their current level of health by
drawing a line from a box outside the rating scale to a point on the scale that reﬂects their current health
state. The EQ-VAS is the only measure collected as part of the PROM programme that does not require
aggregation of multiple dimensions of questionnaire items into an index score. This allows us to analyse
responses to this instrument without making any adjustments to the reported values.
The condition-speciﬁc instruments are the Oxford Hip Score (OHS), the Oxford Knee Score (OKS) and the
Aberdeen Varicose Vein Questionnaire (AVVQ). The OHS and OKS each comprise 12 questions that reﬂect
limitations in health-related quality of life brought about by the either the hip or the knee joint.33,34
Responses to each question are recorded on an ordinal scale ranging from 0 to 4, where 0 indicates
several problems and 4 indicates no problems. An overall score is calculated by weighting questions
equally and summing all answers. Accordingly, the overall scores range from 0 (worst) to 48 (best). The
AVVQ contains 13 questions which can also be aggregated into an index score.35 This index score lies
between 0 and 100, with higher numbers indicating worse health states; however, in order to facilitate
interpretation and comparison of estimation results, we recode the AVVQ scores so that they range from
0 (worst) to 100 (best). No condition-speciﬁc PROM is collected for groin hernia repair.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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able to explore whether or not results are sensitive to the choice of PROM instrument. These sensitivity
analyses are intended to provide insight into which PROM instrument should be used to measure
outcomes. For the comparative analysis reported in The relationship between costs and outcomes, we
include only observations for which the full set of PROMs was completed.Resource useResource use is measured as either inpatient costs or LoS. We derive information on hospital costs from
the RC database, which is an annual compilation of cost data that forms the basis for the calculation of
reimbursement tariffs under Payment by Results36 and whose completion is compulsory for all
NHS-operated hospitals.37 LoS is derived directly from HES.
Reference costs are measured using a top-down costing methodology. The NHS Costing Manual37 sets out
rules to ensure that costs are matched as closely as possible to the services that generate them and to
maximise direct attribution of costs in preference to apportionment. Costs are calculated on a full
absorption basis, meaning that they should reﬂect the full cost of the service delivered and have to
reconcile back to the general ledger. Total hospital costs are assigned to increasingly more granular levels
of a hierarchy of costing centres; beginning at treatment services, to specialties and then to individual
HRGs. Costs at the HRG level are reported separately by specialty and are further broken down by
admission type (day case, elective and emergency care) and LoS, where HRG-speciﬁc trim points are used
to differentiate short, usual and long inpatient spells. Our process of linking RC to HES records generates
costs that are the most speciﬁc to an individual patient that can be achieved given the top-down cost
allocation methods that are used by English hospitals.
All costs are adjusted for the market forces factor (MFF) speciﬁc to the hospital.38 This adjustment takes
into account the unavoidable variation in input prices across the country as deﬁned by the Department
of Health.
Costs are often preferred to LoS as a proxy of resource use because, in theory, they summarise the range
of inputs utilised in the production process. However, the true costs of production are difﬁcult to assess,
particularly in terms of allocating shared inputs, and the reported RCs may be prone to measurement
error. (We exclude one hospital from the analysis of cost and outcomes because of obviously incorrect RC
data. The average cost of care in this hospital for the hip replacement patients in our sample was reported
to be £79, which is impossible under all reasonable explanations. The hospital reported similarly unrealistic
costs for the other three conditions.) LoS, while being a less comprehensive measure of resource use, is
less likely to be affected by measurement error. We therefore explore the sensitivity of our results to the
choice of resource use measure.Observed patient characteristics and risk factorsWe derive a generic set of risk-adjustment variables that reﬂect patient severity and are used to model
both resource use and health outcomes for all four surgical procedures. This builds on the preliminary
risk-adjustment methodology developed by the NHS Information Centre that was, until recently, applied to
the PROM data.9
The primary risk adjuster is the patient’s self-reported health status before surgery, i.e. the pretreatment
PROM. We argue that this captures information about an individual patient that could not be captured by
the other observable characteristics in the HES dataset (e.g. age, gender, etc.). For example, we may know
that older patients in general may have lower outcomes or higher costs, but knowing a patient’s speciﬁc
pretreatment PROM allows far greater scope in understanding the expectations for this particular patient.9
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10The ability to use pretreatment PROM scores as a risk-adjusting variable is thus a major advance in
risk adjustment.
In addition, we also extract information on age, gender and number and type of comorbidities
[International Classification of Diseases – Tenth Edition (ICD-10)] from the HES inpatient dataset. The
number and type of comorbidities are used to account for the number of additional diagnoses coded and
to construct the weighted Charlson index;39 6 of the 17 Charlson comorbidities are designated as severe
and given greater weight than the other eleven.40 We also record whether the patient underwent revision
surgery (based on Ofﬁce of Population Censuses and Surveys procedure classiﬁcation, version 4.5) or
whether the patient was treated by multiple consultants during his or her hospital stay. The patient’s
socioeconomic status is approximated by the income deprivation proﬁle of the neighbourhood in which
the patient resides [i.e. the Index of Multiple Deprivation (IMD)].
We also construct indicator variables for the ﬁve most common HRGs to which patients are allocated and
group all other observations in the category ‘other’. HRGs are, by design, homogeneous with respect to
the expected level of resource utilisation. They are, therefore, expected to explain a majority of variation in
observed cost of treatment or LoS. In contrast, HRGs are not designed or validated to categorise risk
proﬁles with respect to health outcomes. We therefore include HRG dummies in the resource use
equations but not in the outcome equations.
Finally, we derive two variables that are expected to reﬂect hospital production constraints. We calculate
the number of patients treated for each of the four conditions by each hospital. Volume has been
identiﬁed as one potential driver of resource use and health outcomes.41 Given the excess demand faced
by most English NHS hospitals, we expect volume to be outside the hospitals’ control, at least in the short
term and, therefore, we adjust all performance estimates accordingly. Hospitals may also face production
constraints because of existing teaching commitments. We therefore categorise hospitals into teaching and
non-teaching facilities based on the classiﬁcation system adopted by the National Patient Safety Agency.42Missing dataParticipation in the PROM survey is mandatory for hospitals, but optional for patients. As such, one would
expect that some eligible patients do not participate and health status measures are missing. This may be
because patients either did not complete the pretreatment survey (both data points are missing) or
patients were lost to follow-up (one data point is missing). This raises the questions (1) whether the
patients for whom PROM data are missing differ systematically from those who provided data and
(2) whether there are systematic differences among hospitals with regard to the type of patients have
missing data.
The key to dealing with missing data is to understand the mechanism that drives the ‘missingness’ and the
differing consequences that follow. There are, generally argued to be, three missing data mechanisms:43,44
1. Missing completely at random (MCAR): missing data have no systematic relationship to the value of
any other observed or unobserved variables or the value of the missing data item itself. The mechanism
that drives the missingness is purely exogenous and has no implications for the analysis other than that
it reduces sample size.
2. Missing at random (MAR): missing data may be systematically related to the value of other observed
variables (e.g. data for males are less likely to be missing), but conditional on those values, the data are
MCAR. In other words, the data about the outcomes for males that we do observe are representative
of the outcomes for males we do not observe. The important aspect in this case is that the missing
values are related to observable characteristics of individual patients, not to characteristics that
are unobserved.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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item itself or other unobserved characteristics. Effectively, the patients we do observe for a particular
hospital may not be representative of the patients who we do not observe. If, for example, sicker
patients were less likely to ﬁll out post-treatment questionnaires, then the mean health outcome
observed for any particular hospital would be an overestimate.
Missing data pose substantial problems for any type of analysis. The problem is that, by the very nature of
the data being missing, it is virtually impossible to determine which type of missing mechanism is in
operation. Indeed, even if one could be certain that the data are MAR, i.e. they are missing because of the
value that a certain other variable takes, one can rarely provide conclusive evidence for them not being
MNAR. In this sense, the problem of missingness can only truly be overcome by actually collecting the
missing data.
Our study is a secondary data analysis and resources were not available to collect primary data. We
therefore adopt two strategies to address the issue of missing data. First, we report characteristics of
patients who did or did not provide data to allow readers to assess the degree of missingness and come to
a judgement about the data-generating mechanism at work. Second, the analysis reported in Identifying
variation in patient-reported outcomes across hospitals makes use of the unique data structure and
analytical techniques developed in the context of multilevel modelling to condition observed patient
characteristics for those patients who have at least provided pretreatment health status information, and
analyse the data under the less restrictive MAR assumption. Observations for which both data points are
missing are still treated as MCAR.
The analysis reported in The relationship between costs and outcomes operates under the assumption of
MCAR for both pre- and post-treatment health status data owing to constraints imposed by the
analytical model.11
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Based on the two research questions developed in Chapter 2 of this report, we develop differentstatistical approaches to assess hospital performance with respect to, ﬁrst, their ability to promote PROs
and, second, to balance the pursuit of outcomes and cost control. The two research questions are pursued
individually and are thus outlined separately.Identifying variation in patient-reported outcomes
across hospitals
Methodology and statistical approach
The objective of the ﬁrst set of empirical analyses is to obtain estimates of the relative systematic impact of
hospital providers on patients’ post-treatment health outcomes. We estimate hierarchical ordered probit
models45–47 separately for each of the ﬁve dimensions in the EQ-5D questionnaire and then compare the
results with those obtained from a linear regression on the EQ-5D utility scores to study the practical
implications of using disaggregated health dimensions for assessment of hospital performance.
The intuition underpinning the ordinal model is that patient health status (with respect to a given
dimension of the EQ-5D, e.g. pain/discomfort) is continuous, but cannot be directly observed. If health
could be observed, one could directly measure the average effect of treatment and the variation in
treatment effect between hospitals. However, because health is not observable, patients are asked to
classify their underlying health according to a measurement model, leading to three possible classiﬁcations,
i.e. no, some or extreme problems. This classiﬁcation is based on cut-off points, which are also not directly
observable but can be estimated from the data. For example, if a patient’s underlying health status is
higher than cut-off κ2, but lower than cut-off κ1, then the patient will classify himself or herself as having
‘some problems’. This is depicted in Figure 2. By assuming a probability distribution for the possible
classiﬁcations and using the observed patient classiﬁcations, we can estimate the cut-off points and study
movements between classiﬁcations brought about by treatment. This is shown in Figure 3.
More formally, let Hijt* denote the health status of patient i = 1, . . . , nj in hospital j = 1, . . . , J at time point
t e [0,1]. Health status is assumed to be continuous and ranges from negative inﬁnity to positive inﬁnity.
However, health status is not directly observable and, instead, we observe patients’ own assessment of
their status on the three-point EQ-5D response scale (m = 1, 2, 3 with 1 = no problems, 2 = some
problems, 3 = extreme problems). The mapping of underlying, continuous status Hijt* to observed, discrete
health status category Hijt is given by the standard measurement model:48
Hijt ¼ f3 if H*ijt ≤ κ12 if κ1 < H*ijt ≤ κ2
1 if H*ijt > κ2
ð9Þ
where the threshold parameters, κ, are unobserved and must be estimated from the data. The categories
are ordered from worst to best. This facilitates the qualitative interpretation of regression coefﬁcients,
where a positive sign indicates improvements in underlying health and, thus, the probability of reporting
no problems.
Each patient provides measures of his or her health status pre and post treatment. Both responses are
determined partly by common factors, such as patient characteristics and underlying health. Our interest
lies in the change between pre- and post-treatment health status and the degree to which variation in this
health outcome can be systematically associated with the hospital providing the care. We make the
assumption, based on the conditional pretreatment health status of a patient and a set of risk-adjustment13
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Extreme problems
p(H0 = 3)
p(H0 = 2)
p(H0 = 1)
κ1 κ2H*0
Some problems No problems
FIGURE 2 The measurement model of self-reported health classification.
p(H1 = 3)
p(H1 = 2)
p(H1 = 1)
κ1 κ2H*0 H*1
Treatment
effect
Extreme problems Some problems No problems
FIGURE 3 Identifying treatment effects in self-reported health classification.
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14factors, that patients do not select hospitals based on unobservable characteristics and that the health of
patients in different hospitals would follow the same trajectory if untreated. This allows us to interpret the
variation in health outcome across hospitals as a measure of relative quality performance.
Our data are characterised by a hierarchical structure, with measurement points clustered in patients,
which themselves are clustered in hospitals. Given the non-linear nature of our model, these data can be
analysed in two ways. One can collapse the hierarchy into two levels and model post-treatment health
status as a function of lagged, observed (pretreatment) response Hij0, observed patient characteristics and a
hospital effect.49 The alternative way can treat both pre- and post-treatment health status as left-hand-side
variables and estimate longitudinal models with unobserved patient heterogeneity.47,50,51 We adopt the
second approach because it allows us to (1) explicitly account for unobserved, time-invariant determinants
of underlying health, (2) utilise information contained in both the pre- and post-treatment observations to
estimate threshold parameters, (3) acknowledge heterogeneity in underlying health within a health status
category as well as random error in reported pretreatment health, and (4) extend the model in a natural
way should more measurement points become available in the future.52 Furthermore, it allows us to
incorporate information on patients who reported their health status prior to treatment but were
subsequently lost to follow-up. The missing data for these patients are treated as MAR, an improvement
over the MCAR assumption that underpins the two-level regression approach.
Health status at any time point t is described by the equation
H*ijt ¼ αij þ ζj þ x′ ijβ þ T ′υj þ ðT *xijÞ′δþ εijt ð10ÞNIHR Journals Library www.journalslibrary.nihr.ac.uk
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υj ¼ μþ γ j ð11Þ
The vector xij is a set of patient-level risk-adjustment variables that are, in this case, time invariant, where
beta (β) is the estimate of the inﬂuence of each variable. Treatment is modelled as a dummy variable T,
which takes a value of 1 if t = 1 (post-treatment) and 0 otherwise. The direct effect of treatment on
post-treatment health is given by the coefﬁcient υj. We also interact T with xij to allow for differential
effects of patient characteristics on pre-treatment health status and on the effect of treatment.
Unexplained variation is composed of four variance components: (1) a patient-speciﬁc intercept αij∼Nð0,σ2αÞ
that captures unobserved, time-invariant patient heterogeneity in underlying health, (2) a hospital-speciﬁc,
time-invariant intercept ζj∼Nð0,σ2ζÞ that addresses hospital clustering, (3) a random coefﬁcient γ j∼Nð0,σ2γ Þ
that varies between hospitals and describes the systematic hospital effect on post-treatment health and
(4) a serially uncorrelated error term εijt∼Nð0,1Þ that leads to the well-known probit speciﬁcation.
Covariance terms between random effects on the same level of the hierarchy are freely estimated, whereas
terms across levels are constrained to zero. The variance partition coefﬁcient τ describes the extent to
which unexplained variation in post-treatment health occurs at the level of the hospital and is calculated
as follows:53
τ ¼ σ
2
γ þ 2*cov ðζ,γÞ þ σ2ζ
σ2α þ σ2γ þ 2*cov ðζ,γÞ þ σ2ζ þ σ2ε
ð12Þ
Larger values of τ indicate that more variation in post-treatment health is attributable to variation among
hospitals as captured in the hospital-level intercept ζj and the random coefﬁcient on treatment υj.
For the EQ-5D utility model, we adapt our empirical model to a linear speciﬁcation with an identity link
function (i.e. H*ijt ¼ Hijt) and εijt∼Nð0,σ2εÞ.
Our interest lies in estimates of the relative quality of each hospital, γj, captured by the hospital-speciﬁc
deviation from the average effect of treatment, μ. This parameter is not directly estimated but can be
evaluated in post-estimation using Bayes’ theorem with variance estimates entered for the unknown
population parameters, which is a technique known as Empirical Bayes prediction.54
The empirical Bayes estimates (EBEs) are estimated in two distinct steps. First, the risk-adjustment model is
estimated using individual patient-level data while recognising the clustering of patients within hospitals.
Secondly, using this distribution as an ‘empirical’ prior, we can then obtain hospital-speciﬁc estimates.
In the ﬁrst step, the clustering is treated more as a data problem than as a parameter of interest and the
systematic hospital effects are integrated out of the data in order to provide unbiased and precise
estimates of the impact of the observed characteristics.
This ﬁrst-step regression provides us with two important pieces of information. First, it gives us the means
to quantify the expected impact of patient characteristics on outcomes and, thus, identify any
hospital-level deviations not due to case mix. Second, it provides an estimate of the variance parameter σ2γ
and hence the distribution γ j∼Nð0,σ2γ Þ from which the hospital effects are assumed to be drawn. Using this
distribution as an empirical prior, we can then obtain hospital-speciﬁc estimates, γˆ j, in a second step by
applying Bayes’ theorem; that is, the posterior distribution of an individual hospital effect γj shown as
pðγ jjHj, x.j ; βˆÞ∝ pðγ jjx.j, βˆÞpðHjjx.j ; βˆ, γ jÞ ð13Þ15
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16is a function of the likelihood of the observed outcomes, pðHjjx.; βˆ,γ jÞ, i.e. the likelihood of observing
outcomes, Hj, in hospital, j, given the case mix, x.j, the estimated impact of the risk adjusters, βˆ and a
random effect γj, multiplied by the prior distribution of γj, that is pðγ jjx.; βˆÞ.
It can be seen that where the posterior equation has a likelihood that dominates the prior, the
random-effect estimate will be the same as the ﬁxed-effect estimate, a scenario that would typically occur
when sample sizes are large or random noise is small. Conversely, if sample sizes for each individual
hospital are small, then there will be a divergence between the ﬁxed- and random-effect estimates
because the distribution of the likelihood implied by the data is different to that of the prior. More
speciﬁcally, the random-effects model will produce estimates that are drawn towards the prior mean,
zero, which is a process known as shrinkage. This can be interpreted as the estimated reliability of the
ﬁxed-effect estimate as a measure of γj.54 Alternatively, the random-effect estimate itself can be regarded
as a precision-weighted estimate.55
Based on estimates of γj, we can now proceed to describe hospital performance. For non-linear models,
we do this in two different ways. First, we rank hospitals according to their impact on latent
post-treatment health status H*ij1. This can be directly inferred from γˆ j, where a greater number of positive
values indicate better performance. Second, we compute the probability of reporting a speciﬁc
post-treatment health status category (m = 1, 2, 3), based on the estimated effort exerted by the hospital
in providing high-quality care, as determined indirectly from the equations. For the average patient treated
in a hospital of average patient intake, this is given by
ProbðHj1 ¼ mj x,γˆ j,αˆ ij ¼ ζˆ j ¼ 0Þ ¼ Φðκm−Sj1Þ−Φðκm−1−Sj1Þ ð14Þ
where
Sj1 ¼ μˆ þ x′βˆ þ x′δˆ þ γˆ j ð15Þ
and κ0 ¼ −∞,κ3 ¼ þ∞. We calculate 95% credible intervals (CrIs) around γˆ j based on their posterior
distribution. Because our interest is on proﬁling hospital performance, we do not consider uncertainty in
other parameter estimates when calculating CrIs for Prob(yj1 =m).
Both methods produce identical rankings of relative hospital performance. However, only the second
method relates the result back to the original scale of the PRO survey instrument and allows differences
across hospitals to be investigated in terms of the probability of achieving a speciﬁc health outcome.
For the linear model on the EQ-5D index values, we rank hospitals directly on the basis of estimates of γj.
All ordered probit models are estimated by maximum likelihood using Generalised Linear Latent and Mixed
Models computer package (GLLAMM) in Stata 12 (StataCorp LP, College Station, TX, USA), where the
integrals for the random effects are approximated by adaptive quadrature.56 Threshold parameters and the
scale of the coefﬁcient are identiﬁed through constraints on the mean and variance of the error term and
the mean of the intercept. The linear EQ-5D utility model is estimated by maximum likelihood using
xtmixed in Stata 12.0.Descriptive statistics
Patient level
Our sample consists of 27,133 patients having a hip replacement in a total of 154 NHS and private
hospitals. The number of patients in each hospital ranges from 1 to 1212 [mean = 176, standard deviation
(SD) = 148]. A total of 79.8% (n = 21,645) of these patients provide a complete EQ-5D health proﬁle bothNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1pre and post treatment. The remaining 20.2% (n = 5488) only provide a complete pretreatment EQ-5D
health proﬁle. We present descriptive statistics of patient characteristics in Table 2.
Elective hip replacement surgery is performed predominantly on elderly patients (the mean age of
patients = 67.4 years, SD = 11.4 years), with osteoarthritis being the most common reason for surgical
intervention. The majority of patients in our sample are female (58.3%) and 7.6% of patients are admitted
for revision surgery. The average time elapsed between preoperative assessment and date of admission is
20 days (SD = 18.8 days) and the mean follow-up period is 207 days (SD = 29.8 days).
Table 3 presents the transition matrices for each of the ﬁve dimensions in the EQ-5D. For usual
activities, 12,652 (8842 + 1395 + 2415) patients report improvements in mobility after treatment,
761 (289 + 24 + 448) report deteriorations after treatment and 8963 (1065 + 7340 + 558) report no
change. Table 3 also reports the pretreatment health status for patients who did not provide a
post-treatment follow-up measure, but we do not consider them in the following discussion.
Several interesting observations can be made from these data. First, the number of patients improving
after treatment varies greatly by the health dimension under consideration. The dimension most improved
after treatment is pain/discomfort, where 72.4% [(7482 + 3923 + 4686)/(11,553 + 9759 + 898)] of the
patients in our sample report improvements as indicated by a transition to a more favourable category.
This is consistent with clinical expectations and the general understanding that pain reduction (and
improvements in physical function) is the most important outcome for hip replacement patients.59TABLE 2 Descriptive statistics of patient characteristics – hip replacement
Variable Description Mean/% SD Minimum Maximum
male = 1,a if patient is male 41.7% 0.49% 0 1
age Patient’s age (years) 67.41 11.40 15 96
wcharlson Weighted Charlson index of
comorbidities
0.32 0.67 0 8
add_diagnoses Number of additional diagnoses
not included in Charlson index
1.94 1.85 0 18
revision_complications = 1,a if revision surgery because of
complication with existing implant
(ICD-10: T84)57
6.7% 0.25% 0 1
revision_other = 1,a if revision surgery for other
reasons
1.0% 0.10% 0 1
osteoarthritis = 1,a if main diagnosis is osteoarthritis
(ICD-10: M15–19)57
86.4% 0.34% 0 1
rheumatoid_arthritis = 1,a if main diagnosis is rheumatoid
arthritis (ICD-10: M05–06)57
0.5% 0.07% 0 1
other_maindiag = 1,a if main diagnosis is not
osteoarthritis or rheumatoid arthritis
6.0% 0.24% 0 1
deprivation IMD, income domain58 0.13 0.10 0.01 0.83
pretest Time between preoperative
assessment and admission (days)
19.82 18.84 0 84
post-test Follow-up (days) 207.16 29.81 140 365
n Total number of patients 27,133
J Hospitals 154
a values either equal 0 or 1.
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TABLE 3 Transition matrices for EQ-5D dimensions – hip replacement
Pretreatment
Post-treatment
No
(= 1)
Some
(= 2)
Extreme
(= 3)
No
follow-up Total
Mobility
I have no problems in walking about (= 1) 1218 257 0 171 1646
I have some problems in walking about (= 2) 11,030 9769 14 4535 25,348
I am confined to bed (= 3) 17 68 4 50 139
Total 12,265 10,094 18 4756 27,133
Self-care
I have no problems with self-care (= 1) 9076 929 13 1629 11,647
I have some problems with self-care (= 2) 7868 4210 72 2910 15,060
I am unable to wash or dress myself (= 3) 78 155 54 139 426
Total 17,022 5294 139 4678 27,133
Usual activities
I have no problems with performing my usual
activities (= 1)
1065 289 24 206 1584
I have some problems with performing my usual
activities (= 2)
8842 7340 448 3198 19,828
I am unable to perform my usual activities (= 3) 1395 2415 558 1353 5721
Total 11,302 10,044 1030 4757 27,133
Pain/discomfort
I have no pain/discomfort (= 1) 148 44 1 37 230
I have some pain/discomfort (= 2) 7482 5029 245 2320 15,076
I am extreme pain/discomfort (= 3) 3923 4686 652 2566 11,827
Total 11,553 9759 898 4923 27,133
Anxiety/depression
I am not anxious/depressed (= 1) 11,878 941 60 2226 15,105
I am moderately anxious/depressed (= 1) 5635 2471 199 2155 10,460
I am extremely anxious/depressed (= 3) 492 451 163 462 1568
Total 18,005 3863 422 4843 27,133
ANALYSIS
18In contrast, only 29.5% [(5635 + 492 + 451)/(18,005 + 3863 + 422)] of patients report improvements from
one category to another on the anxiety/depression dimension.
Second, the idiosyncratic labelling of the mobility question is clearly reﬂected in the distribution of
pre- and post-treatment scores.60,61 Of those reporting both pre- and post-treatment health status,
only 89 (17 + 68 + 4) patients report being conﬁned to bed prior to treatment, further reducing to
18 after treatment.
Finally, for each of the ﬁve dimensions, a considerable number of patients report no problems prior to
treatment. This is especially pronounced on the dimensions self-care and anxiety/depression where 44.6%
[(9076 + 929 + 13)/(17,022 + 5294 + 139)] and 57.8% [(11,878 + 941+ 60)/(18,005 + 3863 + 422)] of
patients fall into this category, respectively. A total of 6.6% [(1218 + 257 + 0)/(12,265 + 10,094 + 18)] ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1patients report no problems prior to treatment with respect to mobility. Overall, 64 patients report having
no problems with respect to any of the EQ-5D dimensions.
Figure 4 presents the empirical distribution of both the pre- and post-treatment EQ-5D utility scores. We
focus on patients who have reported their health status at both occasions. The mean pretreatment score is
0.354 and the mean post-treatment score is 0.764. Both distributions exhibit typical characteristics of
empirical EQ-5D distributions observed for a wide range of medical conditions, including multimodality,
discontinuity and clustering at 1 (‘full health’).18,19 A total of 87.3% of patients report improvements in
health as measured by the EQ-5D utility index, whereas 6.4% report deteriorations.
Hospital level
Figure 5 shows hospital-level proportions of patients reporting each of the three potential responses
(m = 1, 2, 3, i.e. no, some, extreme problems) for each dimension ordered by decreasing levels of patients
reporting no problems. The pre- and post-treatment graphs for each dimension are shown side by side to
demonstrate the unadjusted changes in pretreatment to post-treatment health status.
The following features are of interest. First, in all dimensions, there is a distinct improvement in average
patient health outcome. This is most clearly indicated by the increase in the proportion of ‘no problems’
(lightly shaded areas) in the post-treatment (right-hand side) graphs. This is most notable for the mobility,
usual activities and pain/discomfort dimensions.
Second, and correspondingly, there are large areas of pretreatment ‘extreme problems’ (darkest
shaded areas) scores that do not appear post-treatment. This is most evident for usual activities and
pain/discomfort.
Third, consider the slope of the boundary between the ‘no problem’ and ‘some problem’ areas for the
post-treatment graphs. This pronounced slope indicates that there is the variation across hospitals in the
proportion of patients in these two categories for all ﬁve dimensions. This occurs regardless of the amount
of pretreatment variation.
This variation across hospitals requires investigation to determine whether it is due to the different
characteristics of patients treated in these hospitals or is due to the performance of the hospital itself.Missing data
Table 4 presents a comparison of patient characteristics across three groups of patients, those that
provided health status measures either (1) at both pre- and post-treatment, (2) only at pretreatment or
(3) never. The group means for each characteristic are compared by one-way analysis of variance method
with Welsh’s test for unequal variances.
There are statistically signiﬁcantly differences for patient medical and demographic characteristics across
groups, as would be expected given the large sample size. Patients who answer both pre- and post-
treatment surveys, on average, have fewer comorbidities and a lower weighted Charlson score, are less
likely to undergo revision surgery and are more likely to have a primary diagnosis of osteoarthritis.
However, these differences are generally small and, arguably, of limited clinical signiﬁcance.Effect of observed patient characteristics on post-treatment health status
Table 5 presents parameter estimates and associated standard errors (SEs) for each of the ﬁve dimension
models and the EQ-5D utility index model.
We ﬁnd several variables to be associated with a higher level of reported health status. Those variables
that are negatively associated with higher health status include a higher weighted Charlson index score, a
greater number of additional comorbidities, being aged 80 years or older (relative to age 61–70 years),
having a main diagnosis other than osteoarthritis and the deprivation proﬁle of the patient’s19
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FIGURE 4 Distribution of the EQ-5D utility scores before and after hip replacement surgery. (a) Pretreatment; and
(b) post-treatment.
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22neighbourhood of residence. Variables that are positively associated with higher health status include
being male and the reports provided by patients admitted for revision surgery tend to show better health
status on mobility and pain/discomfort than those undergoing primary surgery, but tend to be worse with
respect to anxiety/depression. Patients who responded to the pretreatment survey sooner, i.e. the time
elapsed between survey and admission is greater, tend to report better health status, but the effect of this
better health status is very small.
The mean effect of treatment on post-treatment health is positive and signiﬁcant for all dimensions. We
observe some variation in treatment effect that is associated with observed characteristics of the patient, as
captured by the interaction terms. For example, the number of comorbidities and the indicators for revision
surgery are negatively associated with the treatment effect, indicating that treatment is less beneﬁcial for
multimorbid or revision patients. Similarly, patients living in more deprived areas experience, on average,
less improvement in health than those residing in higher income areas. The timing of the post-treatment
survey response has a statistically signiﬁcant, but small, effect and patients who provide a PRO after a
delay indicate that treatment has less of an effect.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 4 Comparison of patient characteristics across response groups
Variablea
Not reported or
excluded
[mean (SD)]
Pretreatment
only
[mean (SD)]
Pre- and
post-treatment
[mean (SD)] p-value
male 0.40 (0.49) 0.41 (0.49) 0.42 (0.49) 0.000
age 68.57 (11.73) 65.95 (13.78) 67.79 (10.69) 0.000
wcharlson 0.35 (0.73) 0.39 (0.77) 0.30 (0.64) 0.000
add_diagnoses 2.11 (1.97) 2.19 (2.04) 1.87 (1.79) 0.000
revision_complications 0.12 (0.32) 0.09 (0.28) 0.06 (0.24) 0.000
revision_other 0.02 (0.14) 0.01 (0.11) 0.01 (0.1) 0.000
osteoarthritis 0.79 (0.41) 0.83 (0.37) 0.87 (0.33) 0.000
rheumatoid_arthritis 0.01 (0.08) 0.01 (0.09) 0.00 (0.07) 0.018
other_maindiag 0.08 (0.27) 0.07 (0.25) 0.06 (0.23) 0.000
deprivation 0.13 (0.1) 0.15 (0.11) 0.12 (0.09) 0.000
n 39,699 5488 21,645
a see Table 2 for descriptions of all variables.
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1As shown in Table 5, all variance components are statistically signiﬁcant at the 95% conﬁdence level,
as conﬁrmed by likelihood ratio tests. In contrast, only the covariance term in the anxiety/depression and
EQ-5D utility models are statistically signiﬁcant. Only about 1.0% (anxiety/depression) to 2.9% (mobility) of
the unexplained variation in underlying health is estimated to be associated with the hospital itself.Risk-adjusted hospital performance on individual EQ-5D dimensions
We now turn to the results of the hospital performance assessment. Figure 6 presents estimates of hospital
performance on the underlying health scale (left-hand graphs) and the probability scale (right-hand
graphs), where the latter is calculated for the average diagnoses. Figure 7 presents the results of the
EQ-5D utility model, where performance is measured directly on the utility scale. Hospitals located to the
left side of each graph perform better than those to the right. The probability of reporting ‘extreme
problems’ after surgery is close to zero for all models. We refrain from reporting CrIs around these
predicted probabilities to increase the readability of the graphs.
The graphical presentation of random coefﬁcients as a caterpillar plot is informative in several ways.
First, we ﬁnd that variation among hospitals, as evidenced by the slope of the curve, is most pronounced
on the mobility and usual activities dimensions. This is a reﬂection of the differences in estimated variance
components that carry over to the EBE. Second, we ﬁnd that only a small number of hospitals have a
statistically signiﬁcantly different treatment impact compared with the sample average, here standardised
to zero. However, note that the CrIs are appropriate only for comparisons against zero, but are too wide
for comparison of any two hospitals.62 Third, CrIs on the mobility dimension are wider than on any other
dimension of the EQ-5D. This reﬂects the lesser amount of information contained in the data, with only
two mobility categories being reasonably well populated. The shortcoming of this type of analysis of
hospital-speciﬁc random coefﬁcients is it focuses on underlying health. Although it is possible to assess
statistical signiﬁcance, one cannot make statements about clinical or patient-perceived signiﬁcance on the
basis of the underlying health scale. To address this, we show hospital-speciﬁc probabilities of reporting a
given post-treatment health status. In some cases, we ﬁnd differences between hospitals to be quite
remarkable. For example, the expected probabilities of reporting ‘no problems’ on usual activities,
6 months after surgery, ranges from 30% to 55.9%. In contrast, expected probabilities for the same
category on the self-care dimension are signiﬁcantly less dispersed and consistently above 80% for
all hospitals.23
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28Hospital performance on multiple EQ-5D dimensions
We explore the global agreement between estimates of hospital performance based on individual EQ-5D
dimensions and the utility-weighted EQ-5D index values by calculating Spearman’s rank-order correlation
coefﬁcients (Spearman’s rho) and inspecting correlation patterns visually. Figure 8 shows plots of
performance estimates on the underlying scale (for EQ-5D dimensions) compared with performance
estimates on the EQ-5D utility scale. Consistent with discussion in The correlation between outcomes and
costs and Risk-adjusted hospital performance on individual EQ-5D dimensions, zero indicates performance
according to the benchmark expectation, negative values indicate worse than expected performance and
positive values indicate better than expected performance.– 0.4
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FIGURE 8 Hospital performance estimates on the EQ-5D dimensions and EQ-5D utility scores. (a) Mobility, Spearman’s
rho = – 0.03; (b) self-care, Spearman’s rho = – 0.18*; (c) usual activities, Spearman’s rho = – 0.04; (d) pain/discomfort
Spearman’s rho = – 0.48**; and (e) anxiety/depression Spearman’s rho = – 0.42***. *p < 0.05; **p < 0.01; ***p < 0.001.
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and EQ-5D utility index (Spearman’s rho = 0.48), followed by the anxiety/depression dimension
(Spearman’s rho = 0.42). The rank correlation for all other dimensions and the EQ-5D utility index is smaller
(Spearman’s rho = < 0.2) and, indeed, not statistically signiﬁcantly different from zero for the dimensions of
mobility and usual activities.The relationship between cost of treatment and outcomes
Methodology and statistical approach
To assess the relationship between resource use and health outcomes, we use random-effects multilevel
models to distinguish between systematic hospital-speciﬁc effects, the impact of differing patient case mix
and random variation. The equations are estimated in a seemingly unrelated regression (SUR) framework
to allow for correlation between resource use and health outcomes due to common omitted variables.63
The EBE of the hospital-speciﬁc effects are the main focus of the analysis.
Data are analysed at patient level with patients i = 1, . . . , Nj clustered within hospitals j = 1, . . . , J with
achievements Cij and Hij1 associated with the health production and the cost functions k ε [c, h]. We
assume a linear additive relationship between these achievements and a hospital-speciﬁc intercept, γj,k, a
constant term, αk, a set of patient-level risk-adjustment variables, Xij,k and a set of hospital-level
explanatory variables, Zj,k, all of which may differ across equations. The model can be written as:
h Cij
Hij1
i
¼
h α0,c
α0,h
i
þ
hXij,c 0
0 Xij,h
ih βc
βh
i
þ
hHij0 0
0 Hij0
ih βc
βh
i
þ
h Zj,c 0
0 Zj,h
ih θc
θh
i
þ
h γ j,c
γ j,h
i
þ
h εij,c
εij,h
i
; ð16Þ
where βc, βh, θc and θh are vectors of parameters to be estimated and which relate patient and hospital
characteristics to postoperative health status and costs.
By estimating the model as a system of equations in a SUR framework rather than each equation in
isolation, it is possible to measure directly the covariance and correlation in the error terms at both the
patient and the hospital level. The random effects at patient level are assumed to be a draw from a
bivariate normal distribution such that
h εij,c
εij,h
i
∼BVN

0
0

,

σ2ε,c ρ1σε,cσe,h
ρ1σε,cσe,h σ2ε,h

ð17Þ
and at hospital level
h γ j,c
γ j,h
i
∼BVN

0
0

,

σ2γ,c ρ2σγ,cσγ,h
ρ2σγ,cσγ,h σ2γ,h

ð18Þ
with ρ1ε[– 1,1] being a measure of correlation at patient level and ρ2ε[– 1,1] measuring correlation at
hospital level. Correlation between error terms, which would occur with ρ1 ≠ 0 and/or ρ2≠ 0, indicates
common omitted variables across cost and health production equations at the relevant level. For example,
if there were an omitted patient characteristic that made healthy outcomes less likely while at the same
time increasing costs, we would expect ρ1 to be negative.
The correlation coefﬁcient, ρ2, is of greater interest and reﬂects a population-averaged relationship
between the estimates of γˆ j,c and γˆ j,h. These capture the hospital-speciﬁc effects after allowing for
the hospital’s patient case mix and relevant production constraints, and form our estimate of the
hospital-speciﬁc deviation from the benchmark, i.e. ðEj,k − EkÞ. Accordingly, γˆ j,c above (or below) zero
indicate that, all other things being equal, the hospital has above (or below) average costs, increasing in
the magnitude of the coefﬁcient. Similarly, values of γˆ j,h above (or below) zero indicate that, all other
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30things being equal, the hospital has above (or below) average health outcomes. A positive correlation
coefﬁcient, ρ2, would indicate that higher costs are generally associated with higher health gains (and vice
versa), i.e. a trade-off between efforts to contain costs and provide high-quality care. A negative
correlation would indicate that efforts to contain costs are associated with efforts to provide high-quality
care. A zero correlation would indicate no relationship.
All models are estimated in Multilevel modelling for Windows computer package (MlwiN; Centre for
Multilevel Modelling, Bristol, UK) using iterative generalised least squares (IGLS), equivalent to full
maximum likelihood. Alternatively, we could estimate this model using GLLAMM for Stata 12; however,
MLwiN is computationally more efﬁcient. All data management and visualisations are done in GLLAMM for
Stata 12. The link between GLLAMM for Stata 12 and MLwiN is provided by the user-written program
runmlwin (Centre for Multilevel Modelling, University of Bristol, UK),64 the Stata module for ﬁtting
multilevel models in the MLwiN software package.64 We obtain EBE of γˆ j,c and γˆ j,h with accompanying
95% CrIs in postestimation, with the unknown population parameters substituted by estimated variance
components and parameters. Hospitals are considered to be situated within one quadrant of the
performance space illustrated in Figure 1 if both CrIs do not contain zero.Descriptive statistics
Patient level
Table 6 reports descriptive statistics for patients undergoing each of the four procedures. Our overall
sample consists of 48,008 patients and knee replacement is the most frequently observed procedure and
varicose vein surgery is the least frequently observed.
Mean costs are similar for hip and knee replacements (around £6200) and considerably lower for groin
hernia repair and varicose vein surgery (< £1500). Average LoS is also much lower for the last two
procedures, with such patients rarely requiring an overnight stay. As LoS is measured as full inpatient days,
we observe only very limited variation in this measure of resource use for groin hernia and varicose
vein surgery.
The EQ-5D scores suggest that average post-treatment health status is lower following hip (0.76) and knee
(0.70) replacement than it is for hernia repair (0.88) and varicose vein surgery (0.87). But for the last two
procedures, pretreatment scores are also quite high (> 0.77). In contrast, pretreatment scores are relatively
low for patients about to undergo hip (0.36) and knee (0.40) replacement. The change in mean health
status as a result of surgery is, therefore, quite considerably larger for hip and knee replacement than it
is for hernia repair or varicose vein surgery. The condition-speciﬁc measures, where available, tell a
similar story.
Summary statistics for the variables used as risk adjusters reveal different patterns in the age and gender
proﬁles of the patients undergoing each procedure. They also differ in terms of the complexity measures,
those having hip or knee replacement having higher weighted Charlson scores and more additional
diagnoses than the other patients. There are no obvious differences across procedures in terms of the
socioeconomic deprivation proﬁle of the neighbourhood in which patients reside.
The HRG variables are speciﬁc to each procedure. Over 75% of patients undergoing each type of
procedure are allocated a single HRG, which forms the reference category in each regression.
Table 7 shows the variation in mean PROM scores (pretreatment, post treatment and the difference
between the two), costs, LoS and number of patients treated among hospitals for each of the four
conditions. Patients are clustered in 130 to 146 hospitals and the average number of patients treated by
each hospital ranges from 29 (varicose vein surgery) to 122 (knee replacement surgery). Note that the
presented values describe the characteristics of the distribution of hospital-average scores rather than the
distribution of patient characteristics.
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TABLE 6 Summary statistics – patient level
Variable Description
Hip
replacement
Knee
replacement
Groin hernia
repair
Varicose vein
surgery
Mean SD Mean SD Mean SD Mean SD
Resource use
costs Cost of care
in £000,
adjusted for
MFF
6.22 1.93 6.19 2.06 1.44 0.65 1.21 0.61
los Length of
hospital stay
(days)
5.85 4.05 5.74 3.54 0.42 0.89 0.14 0.47
Post-treatment health
post_cond Post-
operative
condition-
speciﬁc score
38.08 9.41 33.48 10.12 – – 89.38 9.53
post_EQ5D Post-
operative
EQ-5D index
score
0.76 0.25 0.70 0.27 0.88 0.18 0.87 0.19
post_EQVAS Post-
operative
EQ-VAS score
75.37 18.14 71.56 18.69 79.73 15.67 80.25 15.83
Explanatory factors
pre_cond Pre-operative
condition-
speciﬁc score
18.34 8.38 18.81 7.68 0.00 0.00 81.38 9.85
pre_EQ5D Pre-operative
EQ-5D index
score
0.36 0.32 0.40 0.31 0.79 0.19 0.78 0.20
pre_EQVAS Pre-operative
EQ-VAS score
66.16 20.95 68.46 19.21 80.74 14.35 80.45 15.24
age Age of
patient
(years)
67.38 10.85 68.79 9.17 61.23 14.41 52.00 13.92
male Indicator for
male gender
0.43 0.49 0.45 0.50 0.93 0.25 0.35 0.48
wcharlson Weighted
Charlson
index
0.30 0.64 0.36 0.67 0.17 0.48 0.08 0.30
add_diagnoses Number of
additional
diagnoses
1.90 1.79 2.00 1.84 0.90 1.30 0.44 0.90
revision Indicator for
revision
surgery
0.07 0.26 0.05 0.21 – – – –
deprivation IMD –
income
domain58
0.12 0.09 0.13 0.10 0.13 0.10 0.14 0.11
continued
continued
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TABLE 6 Summary statistics – patient level (continued )
Variable Description
Hip
replacement
Knee
replacement
Groin hernia
repair
Varicose vein
surgery
Mean SD Mean SD Mean SD Mean SD
multiepi Indicator for
multiple
consultants
during
hospital stay
0.01 0.12 0.01 0.10 0.00 0.07 0.00 0.05
HRG1 Indicator for
most
common
HRG
0.82 0.38 0.85 0.35 0.83 0.38 0.76 0.43
HRG2 Indicator for
second most
common
HRG
0.04 0.21 0.05 0.22 0.14 0.34 0.11 0.31
HRG3 Indicator for
third most
common
HRG
0.04 0.18 0.05 0.21 0.02 0.13 0.06 0.24
HRG4 Indicator for
fourth most
common
HRG
0.04 0.18 0.03 0.17 0.00 0.06 0.05 0.21
HRG5 Indicator for
ﬁfth most
common
HRG
0.02 0.15 0.00 0.06 0.00 0.06 0.01 0.10
HRGother Indicator for
any other
HRG
0.04 0.19 0.01 0.11 0.01 0.11 0.02 0.12
Number of observations
n Total number
of patients
16,403 17,444 10,389 3772
J Hospitals 142 143 146 130
ANALYSIS
32As with the patient-level descriptive statistics, there are noticeable differences between mean EQ-5D utility
scores across hospitals and conditions, for both pre- and post-treatment scores. This is illustrated in the
box plots in Figures 9–11. The shaded boxes and the ‘whiskers’ are all approximately the same size for all
conditions for pretreatment means and post-treatment means, both within and across procedures. The
observed mean pre- and post-treatment EQ-5D utility scores (Figure 9) are lower for hip and knee
replacement surgery than for varicose vein surgery or groin hernia repair. However, despite the difference
in the general location on the EQ-5D utilities, the variation in means across hospitals is broadly similar,
whether measured by the standard deviation or the interquartile range (IQR), i.e. the difference between
the 25th and 75th percentiles of the distribution. In other words, the three box plots (excluding the
outliers) are generally distinguishable only by their location, not their size.
The EQ-5D utility scores (Figure 9) and condition-speciﬁc measures (where applicable – Figure 11) all
suggest improvements in health status, as indicated by the upward shift in the location of the pre- and
post-treatment box plots. In contrast, the EQ-VAS (Figure 10) shows little change in the pre- and
post-treatment distributions for knees, a negative change for groin hernia and no change for varicose veins.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 7 Summary statistics of average resource use, health status and health outcomes – hospital level
Mean of
sample values SD
Minimum
of sample
values
25th
pct Median
75th
pct
Maximum
of sample
values
Hip replacement (142 hospitals)
Number of patients
treated
115.51 82.81 9 55 97 161 462
Pre-treatment EQ-5D
utility
0.35 0.06 0.10 0.30 0.35 0.39 0.55
Post-treatment EQ-5D
utility
0.75 0.06 0.55 0.72 0.76 0.80 0.89
Change in EQ-5D utility 0.41 0.05 0.19 0.38 0.41 0.44 0.54
Pre-treatment EQ-VAS
score
65.52 3.36 55.72 63.68 65.71 67.50 73.13
Post-treatment EQ-VAS
score
74.74 3.80 54.50 73.20 75.44 77.10 82.33
Change in EQ-VAS
score
9.22 3.90 – 7.90 7.13 9.42 11.65 22.27
Pre-treatment OHS 18.08 1.70 13.50 16.87 17.91 19.22 22.63
Post-treatment OHS 37.75 2.20 29.89 36.64 38.08 39.23 42.11
Change in OHS 19.68 1.79 12.17 18.78 19.76 20.90 23.94
Costs adjusted for MFF
(in £000)
6.29 1.71 1.63 5.22 6.01 7.02 14.75
LoS 6.08 1.25 3.90 5.33 5.96 6.57 13.50
Knee replacement (143 hospitals)
Number of patients
treated
121.99 84.89 1 61 99 171 459
Pre-treatment EQ-5D
utility
0.39 0.07 0.03 0.36 0.40 0.43 0.55
Post-treatment EQ-5D
utility
0.69 0.05 0.49 0.66 0.69 0.73 0.85
Change in EQ-5D utility 0.30 0.07 0.11 0.26 0.30 0.32 0.82
Pre-treatment EQ-VAS
score
67.65 4.59 40.00 65.94 68.11 70.17 77.59
Post-treatment EQ-VAS
score
71.30 3.51 59.85 69.42 71.61 73.91 80.19
Change in EQ-VAS
score
3.65 3.39 – 1.69 1.69 3.17 5.04 25.83
Pre-treatment OKS 18.57 1.92 11.00 17.55 18.62 19.77 22.67
Post-treatment OKS 33.34 2.29 26.47 32.11 33.26 34.94 41.00
Change in OKS 14.77 2.05 10.04 13.62 14.64 15.56 29.00
Costs adjusted for MFF
(in £000)
6.31 1.84 1.54 5.32 5.98 7.01 16.14
LoS 5.90 1.11 3.85 5.21 5.74 6.37 12.67
continued
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TABLE 7 Summary statistics of average resource use, health status and health outcomes – hospital level
(continued )
Mean of
sample values SD
Minimum
of sample
values
25th
pct Median
75th
pct
Maximum
of sample
values
Groin hernia repair (146 hospitals)
Number of patients
treated
71.16 53.29 1 37 61 89 365
Pre-treatment EQ-5D
utility
0.79 0.04 0.60 0.78 0.79 0.82 0.94
Post-treatment EQ-5D
utility
0.88 0.03 0.77 0.86 0.88 0.90 1.00
Change in EQ-5D utility 0.09 0.04 – 0.08 0.06 0.09 0.10 0.31
Pre-treatment EQ-VAS
score
80.63 3.11 67.00 79.12 80.68 82.40 100.00
Post-treatment EQ-VAS
score
79.62 2.67 71.00 77.99 79.69 81.31 87.33
Change in EQ-VAS
score
– 1.01 2.39 – 15.00 – 2.11 – 1.01 0.10 6.56
Costs adjusted for MFF
(in £000)
1.52 0.55 0.53 1.23 1.49 1.77 5.69
LoS 0.44 0.25 0.00 0.27 0.38 0.57 1.37
Varicose vein surgery (130 hospitals)
Number of patients
treated
29.02 32.51 1 8 23 40 190
Pre-treatment EQ-5D
utility
0.77 0.07 0.46 0.74 0.78 0.81 1.00
Post-treatment EQ-5D
utility
0.87 0.09 0.12 0.84 0.88 0.91 1.00
Change in EQ-5D utility 0.10 0.11 – 0.88 0.07 0.10 0.13 0.44
Pre-treatment EQ-VAS
score
80.36 5.89 50.00 77.00 80.04 83.95 95.00
Post-treatment EQ-VAS
score
80.24 5.57 60.00 77.50 81.22 83.83 91.30
Change in EQ-VAS
score
– 0.12 4.58 – 15.67 – 2.56 – 0.36 2.50 20.00
Pre-treatment AVVS 80.76 4.04 66.13 78.95 81.33 83.38 90.39
Post-treatment AVVS 89.33 3.85 66.63 87.45 89.64 91.47 99.33
Change in AVVS 8.56 3.35 – 5.82 6.57 8.82 10.66 19.93
Costs adjusted for MFF
(in £000)
1.22 0.48 0.12 0.86 1.15 1.57 2.53
LoS 0.18 0.23 0.00 0.00 0.11 0.25 1.29
pct, percentile of the distribution.
ANALYSIS
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FIGURE 9 Distribution of average EQ-5D utility scores before and after treatment across hospitals.
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36While the main bodies of the distributions of pre- and post-treatment EQ-5D utility scores across
conditions show little difference, there is a clear change with regards to the distribution of outliers. For hip
replacement, knee replacement and especially groin hernia repair, the dispersion of outliers (shown as
above or below the ‘whiskers’) decreases noticeably after treatment. The exception is varicose vein surgery,
where the dispersion of outliers post treatment is higher than pretreatment and may have been even
higher if utility scores were not bound at the upper limit of one (‘full health’). Such patterns are not
apparent when the EQ-VAS is considered.
Figure 12 shows the distribution of average resource use across hospitals, measured using cost of
treatment and LoS. There are three points of note. First, the location of the cost and LoS distributions is
similar for hip and knee replacement, but the LoS distribution is lower than the cost distribution for groin
hernia and varicose veins. This is because the groin hernia and varicose veins tend to be treated on a
day-case basis. Second, there is a wider distribution for costs than LoS, which reﬂects the fewer and lower
values of LoS compared with cost of treatment. Third, for hip replacement and knee replacement, there
are a handful of hospitals with extreme costs of treatment or LoS. There are just a couple of hospitals at
the upper extremes for groin hernia and varicose veins.
Unadjusted outcome/cost ratios
Figures 13–16 present unadjusted outcome/cost ratios for the four conditions. The IQRs reﬂect the
variability in outcome/cost ratios within each hospital. We do not present graphs with respect to LoS
because many patients, especially those undergoing groin hernia repair or varicose vein surgery, do not
stay overnight and, hence, the ratio of outcomes to LoS is undeﬁned.
Average costs differ substantially across hospitals. This leads to different amounts of health outcome
generated per unit of cost across hospitals. Those hospitals that generate more health outcome per unit of
cost also have a larger IQR, i.e. there is more variability within these hospitals. This ﬁnding is independent
of the PROM used.
Outcome/cost ratios can be compared across procedures when outcomes are measured by the EQ-5D
utility index or EQ-VAS. The highest average level of utility gain per unit of cost is observed for varicose
vein surgery (0.113 per £1000), where a small gain in health outcome is produced at very low costs. The
smallest average utility gain per unit of cost is observed for knee replacement surgery with 0.053 units of
health gain per £1000. Here, the larger utility gains are offset by proportionally higher costs.
As expected from the box plots on pre- and post-treatment operative EQ-VAS scores, we ﬁnd that many
hospitals have, on average, negative EQ-VAS health outcomes that translate into negative outcome/cost15
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FIGURE 12 Distribution of average, unadjusted resource use by hospital.
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IGURE 13 Outcome/cost ratios by hospital – hip replacement. (a) EQ-5D utility index; (b) EQ-VAS; and (c) OHS.
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FIGURE 14 Outcome/cost ratios by hospital – knee replacement. (a) EQ-5D utility index; (b) EQ-VAS; and (c) OKS.
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FIGURE 15 Outcome/cost ratios by hospital – groin hernia repair. (a) EQ-5D utility index; and (b) EQ-VAS.
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1ratios. This is especially pronounced for varicose vein surgery and groin hernia repair, where more than half
of the hospitals achieve negative outcome/cost ratios. This is counter to what we observe for EQ-5D
outcome/cost ratios. Thus, the general interpretation of the unadjusted outcome/cost ratios is sensitive to
the choice of generic PROM used.
Missing data
ded in ourTables 8–11 present a comparison of patient characteristics and resource use for patients inclu
analytical sample with those excluded. Patients are only included if they have provided health status
measures both pre- and post-treatment on all PROMs. For the purpose of the analysis, we pool
observations for patients who (1) did not participate, (2) participated in the initial survey but were lost to
follow-up or (3) participated but provided incomplete data. The groups are compared by means of
two-sided t-tests with adjustment for unequal variances. Additionally, we also ran logistic regressions on
the probability of being included in our estimation sample, conditional on the observed patient
characteristics and the incurred resource use.39
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Street et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
0– 1
1
0
2
3
20 40 60 80C
h
an
g
e 
in
 E
Q
-5
D
 u
ti
lit
ie
s 
p
er
 £
10
00
100 120 140
Hospitals
(a)
Mean effect
25–75 percentile
0
– 100
0
– 50
50
100
20 40 60 80C
h
an
g
e 
in
 E
Q
-V
A
S 
sc
o
re
s 
p
er
 £
10
00
100 120 140
Hospitals
(b)
Mean effect
25–75 percentile
0
– 50
50
100
0
150
20 40 60 80
C
h
an
g
e 
in
 A
V
V
Q
 s
co
re
 p
er
 £
10
00
100 120 140
Hospitals
(c)
Mean effect
25–75 percentile
FIGURE 16 Outcome/cost ratios by hospital – varicose vein surgery. (a) EQ-5D utility index; (b) EQ-VAS; and
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TABLE 8 Comparison of patient characteristics and resource consumption across samples – hip replacement
Variablea Excluded (SD) Included (SD) p-valueb Odds ratio (z-value)
age 68.33 (11.84) 67.38 (10.85) 0.000 1.00 (0.44)
male 0.40 (0.49) 0.43 (0.49) 0.000 1.07 (3.32)
wcharlson 0.35 (0.72) 0.30 (0.64) 0.000 0.94 (3.34)
add_diagnoses 2.09 (1.97) 1.90 (1.79) 0.000 0.98 (1.83)
revision 0.13 (0.33) 0.07 (0.26) 0.000 0.55 (8.21)
deprivation 0.13 (0.10) 0.12 (0.09) 0.000 0.38 (5.70)
multiepi 0.03 (0.18) 0.01 (0.12) 0.000 0.54 (2.29)
LOS 7.01 (7.73) 5.85 (4.05) 0.000 0.94 (6.85)
costs 5325 (3384.40) 6121 (1932.13) 0.000 1.00 (3.62)
constant NA NA NA 0.26 (4.52)
n 50,429 16,403 66,832
NA, not applicable.
a See Tables 2 and 6 for descriptions of all variables.
b Based on a two-sided t-test.
TABLE 9 Comparison of patient characteristics and resource consumption across samples – knee replacement
Variablea Excluded (SD) Included (SD) p-valueb Odds ratio (z-value)
age 69.52 (9.73) 68.79 (9.17) 0.000 0.99 (4.54)
male 0.43 (0.49) 0.45 (0.50) 0.000 1.12 (5.06)
wcharlson 0.38 (0.69) 0.36 (0.67) 0.010 0.97 (1.47)
add_diagnoses 2.09 (1.89) 2.00 (1.84) 0.000 0.99 (0.40)
revision 0.10 (0.30) 0.05 (0.21) 0.000 0.44 (10.93)
deprivation 0.14 (0.11) 0.13 (0.10) 0.000 0.34 (6.19)
multiepi 0.03 (0.16) 0.01 (0.10) 0.000 0.51 (2.49)
LOS 6.43 (6.74) 5.74 (3.54) 0.000 0.95 (5.73)
costs 5097 (3552.49) 6090 (2040.55) 0.000 1.00 (3.26)
constant NA NA NA 0.36 (3.36)
n 55,645 17,444 73,089
NA, not applicable.
a See Tables 2 and 6 for descriptions of all variables.
b Based on a two-sided t-test.
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TABLE 10 Comparison of patient characteristics and resource consumption across samples – groin hernia repair
Variablea Excluded (SD) Included (SD) p-valueb Odds ratio (z-value)
age 58.45 (17.34) 61.23 (14.41) 0.000 1.01 (12.65)
male 0.91 (0.28) 0.93 (0.25) 0.000 1.33 (5.96)
wcharlson 0.21 (0.57) 0.17 (0.48) 0.000 0.89 (5.04)
add_diagnoses 0.96 (1.41) 0.90 (1.30) 0.000 0.97 (1.77)
deprivation 0.14 (0.11) 0.13 (0.10) 0.000 0.25 (6.15)
multiepi 0.01 (0.08) 0.00 (0.07) 0.015 1.26 (1.33)
LOS 0.75 (3.44) 0.42 (0.89) 0.000 0.76 (5.75)
costs 1312 (1101.00) 1415 (636.20) 0.000 1.00 (2.42)
constant NA NA NA 0.07 (13.43)
n 58,449 10,389 68,838
NA, not applicable.
a See Tables 2 and 6 for descriptions of all variables.
b Based on a two-sided t-test.
TABLE 11 Comparison of patient characteristics and resource consumption across samples – varicose vein surgery
Variablea Excluded (SD) Included (SD) p-valueb Odds ratio (z-value)
age 50.88 (15.03) 52.00 (13.92) 0.000 1.01 (3.71)
male 0.37 (0.48) 0.35 (0.48) 0.002 0.89 (2.84)
wcharlson 0.10 (0.38) 0.08 (0.30) 0.000 0.85 (2.80)
add_diagnoses 0.46 (0.94) 0.44 (0.90) 0.098 0.97 (0.75)
deprivation 0.16 (0.12) 0.14 (0.11) 0.000 0.31 (4.50)
multiepi 0.00 (0.04) 0.00 (0.05) 0.688 1.38 (0.82)
LOS 0.20 (1.54) 0.14 (0.47) 0.000 0.82 (2.13)
costs 1012 (900.64) 1192 (600.88) 0.000 1.00 (1.70)
constant NA NA NA 0.09 (13.50)
n 31,582 3772 35,354
NA, not applicable.
a See Tables 2 and 6 for descriptions of all variables.
b Based on a two-sided t-test.
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DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1The differences in medical characteristics between patients who have been included or excluded from the
analysis of resource use and health outcome performance are similar across conditions. We ﬁnd excluded
patients to have a greater number of diagnoses and higher scores on the Charlson index and to be more
likely to undergo revision surgery (only measured for hip replacement and knee replacement). Furthermore,
patients included in our study sample tend to have substantially shorter LoS but incur more treatment costs
than those excluded. While we can control for medical characteristics of the patient in our analysis, we
cannot control for resource use as it constitutes one measure of interest. Hence, we have to acknowledge
that our sample may not be representative for all patients undergoing relevant surgical procedures in the
NHS in terms of severity and resource use.
Comparison of excluded and included sample means allows us to say something about the
representativeness of the patients for whom we have full data and the type of missing mechanism that
may be at play.
Although we can rule out the MCAR mechanism, the analysis is not necessarily biased as many of the
measures are very similar across groups in practical terms. For example, we ﬁnd that the average age in
years between the included and excluded samples is generally within a year of each other. Furthermore,
the regression models all suggest that age has little systematic impact on outcomes. Other variables of
greater practical signiﬁcance (such as revision rates), again, may not cause bias if they are MAR and are
successfully conditioned upon in the regression model. This usually requires making an untestable
assumption that the revision patients included in the analysis are representative of those for whom data
are missing.
For patients for whom PROM data are missing, we do have data about their resource use. Ideally, there
would be no differences in resource use between included and excluded patients; however, both cost of
treatment and LoS are different and the magnitude of the differences suggests that they may be
important. As such, the assumption that data are MAR looks untenable and the regression correction
approach may not resolve the issue.
Of greater importance for our analysis is whether or not there are systematic differences among hospitals
in terms of the type of patients for whom data are missing. If there are differences, this will bias the
estimates of effort for particular hospitals. The bias will be greater the larger any systematic imbalance
across hospitals. To get a greater understanding of this, we plot the proportion of missing patients against
the raw mean changes in health outcomes across hospitals, the motivation being that if non-response bias
were occurring at hospital level then we would be able to identify it on these graphs. A positive correlation
between the two measures could be interpreted as evidence of systematic differences among hospitals in
the type of patients for whom data are missing.
Figures 17–20 show plots of the non-response rate by hospital against their average (unadjusted) health
gain achieved by this hospital. The graphs show that non-response is not correlated with health outcome.
This suggests that, although there is evidence of non-response bias among individual patients, this does
not appear to lead to systematic bias in the hospital-speciﬁc estimates.43
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FIGURE 17 Non-response rates and health outcome – hip replacement. (a) Non-response rate vs. EQ-5D health gain;
(b) non-response rate vs. EQ-VAS health gain; and (c) non-response rate vs. OHS health gain.
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FIGURE 18 Non-response rates and health outcome – knee replacement. (a) Non-response rate vs. EQ-5D health gain;
(b) non-response rate vs. EQ-VAS health gain; and (c) non-response rate vs. OKS health gain.
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IGURE 19 Non-response rates and health outcome – groin hernia repair. (a) Non-response rate vs. EQ-5D health
ain; and (b) non-response rate vs. EQ-VAS health gain.
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FIGURE 20 Non-response rates and health outcome – varicose vein surgery. (a) Non-response rate vs. EQ-5D health
gain; (b) non-response rate vs. EQ-VAS health gain; and (c) non-response rate vs. AVVQ health gain.
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Estimation results for those who had a hip replacement are presented in Table 12. There are six sets of
results, reﬂecting the different combinations of PRO instrument and resource use measure in the SUR
model. The estimated effects of the explanatory variables on postoperative health status are not sensitive
to the choice of resource use measure (cost of treatment or LoS). In contrast, the estimated impact on cost
of treatment or LoS does appear slightly sensitive to the choice of PROM, this being because of how
pretreatment health status is measured in these estimations.
In general, signiﬁcant predictors of post-treatment health are not sensitive to the choice of PROM.
As would be expected, post-treatment health status is negatively related to the weighted Charlson score,
the number of diagnoses, revision surgery and higher neighbourhood deprivation; whereas, it is positively
related to being of male gender and pretreatment health status. The impact of age on post-treatment
health status is negative and signiﬁcant when the EQ-VAS or OHS are considered, but insigniﬁcant when
post-treatment health status is measured by the EQ-5D. The number of patients treated has a positive and
signiﬁcant association with post-treatment health in three of the six models.
With regard to resource use measures, older age, being of male gender, deprivation and higher weighted
Charlson index are positive and statistically signiﬁcant predictors of LoS but are unrelated to cost of
treatment. Both LoS and cost of treatment are higher, and have a positive and signiﬁcant relationship, for
those who have a greater number of diagnoses and if a revision surgery is performed. As expected, there
are also signiﬁcant differences in resource use related to the HRG to which patients are allocated.
The direction and size of these differences are consistent with the tariff payments for these HRGs (not
presented in this report). Resource use is lower and, therefore, negatively related to patients presenting
with a better state of pretreatment health. The number of patients treated has a negative and statistically
signiﬁcant relationship with LoS but not cost of treatment, whereas teaching activity of the hospital has a
positive and statistically signiﬁcant relationship with LoS but not cost of treatment.
After controlling for patient characteristics, there remains signiﬁcant unexplained variation at patient level
in terms of post-treatment health status and resource use, however these are measured. This is indicated
by the signiﬁcance (based on two-sided Wald tests) of σ2ε,h for outcomes, and σ
2
ε,c for resource use. The
covariance between unobserved factors at patient level is negative, i.e. ρ1 < 0, when LoS is considered (any
PROM) or cost of treatment (only OHS). This suggests that common, unobserved patient characteristics
exist that have a positive effect on post-treatment health status and that reduce the amount of resources
used (and vice versa). However, this also suggests that there may be less variability in both generic PROMs
and cost of treatment than in the condition-speciﬁc OHS and LoS.
At the hospital level, we ﬁnd a similar pattern with both σ2γ,h and σ
2
γ,c being statistically signiﬁcant. The
estimated covariance between the hospital effects in each equation is always negative, independent of
how resource use or PROs are measured. However, the covariance estimate is only statistically signiﬁcant in
the EQ-VAS/LoS model. Note that the size of the estimated variance components σ2γ,h differs across PROMs
not least because of the scale of the instrument in question (e.g. the EQ-5D ranges from – 0.542 to 1 and
the EQ-VAS ranges from 0 to 100).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Table 13 presents the regression results for knee replacement surgery. The predictors of post-treatment
health status for those having a knee replacement have the same sign (direction of inﬂuence) as the
predictors of post-treatment health status following hip replacement surgery. Patients report lower
post-treatment health status if they have a higher Charlson score, a greater number of diagnoses and live
in more deprived areas, whereas men and those with higher pretreatment health status report better
post-treatment health status. In contrast to the hip replacement results, age has a positive and statistically
signiﬁcant association with better post-treatment health status following knee replacement. No effects are
identiﬁed regarding number of patients treated or teaching activity of the hospital. The direction and
signiﬁcance of the variables predicting LoS and cost of treatment for patients undergoing knee
replacement are broadly consistent with those for patients having hip replacement.
In general, the variance and covariance parameters at patient level tell a similar story to those for the hip
replacement sample. The variance terms at hospital level are statically signiﬁcant, indicating systematic
variation in both health outcomes and resource use across hospitals. However, the covariance terms are
statistically insigniﬁcant other than for the EQ-VAS and LoS, providing little evidence for a systematic
association between hospital performance in terms of resource use and quality of care.51
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ANALYSIS
54Varicose vein surgery
Table 14 presents the regression results for varicose vein surgery, for which the health outcome models are
broadly in line with those found for hip replacement and knee replacement. Post-treatment health status is
negatively associated with age, weighted Charlson index, number of additional diagnoses and area
deprivation; however, it is positively associated with being of male gender and initial health status,
although the statistical signiﬁcance of these effects is somewhat sensitive to the choice of PROM. With
respect to resource use, we ﬁnd that only the HRG to which the patient is assigned and the number of
additional diagnoses are positive and statistically signiﬁcant predictors for both LoS and cost of treatment.
With respect to the variance and covariance components, we make three interesting observations. First,
the covariance term at patient level is always insigniﬁcant. This suggests that health outcome and resource
use do not depend on common unobserved factors at patient level. Second, the variance component for
the hospital effect in the health outcome equation is insigniﬁcant for both generic PROMs. Hence, both
instruments do not pick up any systematic variation in health outcome across hospitals. In contrast, the
estimated variance σ2γ,h is signiﬁcant when health status is assessed by the AVVQ. Finally, the covariance
terms at hospital level are positive and signiﬁcant for the model considering the AVVQ and cost of
treatment. Hence, there may be unobserved factors that are associated with both systematic variation in
health outcomes and cost of treatment, leading to a positive correlation between the two.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TA
B
LE
14
R
eg
re
ss
io
n
re
su
lt
s
–
va
ri
co
se
ve
in
su
rg
er
y
M
ea
su
re
o
f
h
ea
lt
h
EQ
-5
D
EQ
-5
D
EQ
-V
A
S
EQ
-V
A
S
A
V
V
Q
A
V
V
Q
M
ea
su
re
o
f
re
so
u
rc
e
u
se
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
H
e
a
lt
h
o
u
tc
o
m
e
sa
β
SE
β
SE
β
SE
β
SE
β
SE
β
SE
co
ns
ta
nt
0.
61
0.
02
**
*
0.
61
0.
02
**
*
49
.4
5
1.
60
**
*
49
.4
4
1.
60
**
*
47
.4
7
1.
26
**
*
47
.4
4
1.
26
**
*
ag
e
–
0.
00
0.
00
**
*
–
0.
00
0.
00
**
*
–
0.
12
0.
02
**
*
–
0.
12
0.
02
**
*
–
0.
02
0.
01
*
–
0.
02
0.
01
m
al
e
0.
01
0.
01
0.
01
0.
01
0.
07
0.
46
0.
07
0.
46
1.
38
0.
27
**
*
1.
38
0.
27
**
*
w
ch
ar
ls
on
–
0.
01
0.
01
–
0.
01
0.
01
–
3.
29
0.
75
**
*
–
3.
30
0.
75
**
*
–
0.
76
0.
43
–
0.
76
0.
43
ad
d_
di
ag
no
se
s
–
0.
02
0.
00
**
*
–
0.
02
0.
00
**
*
–
1.
19
0.
26
**
*
–
1.
19
0.
26
**
*
–
0.
22
0.
15
–
0.
22
0.
15
de
pr
iv
at
io
n
–
0.
13
0.
03
**
*
–
0.
13
0.
03
**
*
–
7.
91
2.
10
**
*
–
7.
99
2.
10
**
*
–
0.
40
1.
24
–
0.
51
1.
23
m
ul
tie
pi
0.
12
0.
06
*
0.
12
0.
06
*
5.
53
4.
75
5.
50
4.
75
0.
61
2.
77
0.
62
2.
77
in
iti
al
he
al
th
st
at
us
0.
43
0.
01
**
*
0.
43
0.
01
**
*
0.
49
0.
01
**
*
0.
49
0.
01
**
*
0.
53
0.
01
**
*
0.
53
0.
01
**
*
vo
lu
m
e
–
0.
00
0.
00
–
0.
00
0.
00
0.
00
0.
01
0.
00
0.
01
–
0.
01
0.
00
–
0.
01
0.
00
te
ac
hi
ng
ho
sp
ita
l
–
0.
00
0.
01
–
0.
00
0.
01
–
1.
08
0.
60
–
1.
06
0.
60
–
0.
26
0.
43
–
0.
20
0.
41
R
e
so
u
rc
e
u
se
a
co
ns
ta
nt
0.
01
0.
05
1.
19
0.
07
**
*
0.
01
0.
06
1.
18
0.
07
**
*
0.
15
0.
07
*
1.
22
0.
08
**
*
ag
e
0.
00
0.
00
**
*
0.
00
0.
00
0.
00
0.
00
**
*
0.
00
0.
00
0.
00
0.
00
**
*
0.
00
0.
00
m
al
e
0.
00
0.
02
0.
03
0.
01
*
0.
00
0.
02
0.
03
0.
01
*
0.
01
0.
02
0.
03
0.
01
**
w
ch
ar
ls
on
0.
03
0.
03
0.
02
0.
02
0.
03
0.
03
0.
02
0.
02
0.
03
0.
03
0.
02
0.
02
ad
d_
di
ag
no
se
s
0.
05
0.
01
**
*
0.
02
0.
01
**
0.
05
0.
01
**
*
0.
02
0.
01
**
0.
05
0.
01
**
*
0.
02
0.
01
**
de
pr
iv
at
io
n
0.
08
0.
07
–
0.
02
0.
06
0.
09
0.
07
–
0.
02
0.
06
0.
08
0.
07
–
0.
02
0.
06
m
ul
tie
pi
0.
51
0.
16
**
–
0.
14
0.
13
0.
51
0.
16
**
*
–
0.
13
0.
13
0.
50
0.
16
**
–
0.
13
0.
13
H
RG
2
0.
22
0.
02
**
*
0.
20
0.
02
**
*
0.
23
0.
02
**
*
0.
20
0.
02
**
*
0.
22
0.
02
**
*
0.
19
0.
02
**
*
co
nt
in
ue
d
co
nt
in
ue
d
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1
55
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Street et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
TA
B
LE
14
R
eg
re
ss
io
n
re
su
lt
s
–
va
ri
co
se
ve
in
su
rg
er
y
(c
o
n
ti
n
u
ed
)
M
ea
su
re
o
f
h
ea
lt
h
EQ
-5
D
EQ
-5
D
EQ
-V
A
S
EQ
-V
A
S
A
V
V
Q
A
V
V
Q
M
ea
su
re
o
f
re
so
u
rc
e
u
se
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
H
RG
3
0.
05
0.
03
–
0.
08
0.
03
*
0.
05
0.
03
–
0.
08
0.
03
*
0.
05
0.
03
–
0.
08
0.
03
**
H
RG
4
0.
07
0.
03
*
0.
12
0.
03
**
*
0.
07
0.
03
*
0.
12
0.
03
**
*
0.
07
0.
03
*
0.
12
0.
03
**
*
H
RG
5
0.
56
0.
08
**
*
0.
35
0.
07
**
*
0.
55
0.
08
**
*
0.
35
0.
07
**
*
0.
55
0.
08
**
*
0.
35
0.
07
**
*
H
RG
ot
he
r
0.
41
0.
06
**
*
0.
21
0.
05
**
*
0.
42
0.
06
**
*
0.
22
0.
05
**
*
0.
40
0.
06
**
*
0.
21
0.
05
**
*
in
iti
al
he
al
th
st
at
us
–
0.
02
0.
04
–
0.
03
0.
03
–
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
*
–
0.
00
0.
00
vo
lu
m
e
–
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
te
ac
hi
ng
ho
sp
ita
l
–
0.
02
0.
04
0.
05
0.
11
–
0.
02
0.
04
0.
05
0.
11
–
0.
02
0.
04
0.
05
0.
11
V
a
ri
a
n
ce
co
m
p
o
n
e
n
ts
–
h
o
sp
it
a
l
le
v
e
la
σ2 γ
,h
0.
00
0.
00
0.
00
0.
00
1.
04
0.
77
0.
96
0.
76
1.
18
0.
42
**
1.
06
0.
39
**
co
v(
γ h
,
γ c
)
–
0.
00
0.
00
0.
00
0.
00
0.
07
0.
04
0.
15
0.
11
0.
05
0.
03
0.
22
0.
08
**
(0
.0
0)
(0
.0
0)
(0
.0
4)
(0
.1
1)
(0
.0
3)
(0
.0
8)
σ2 γ
,c
0.
02
0.
00
**
*
0.
20
0.
03
**
*
0.
02
0.
00
**
*
0.
20
0.
03
**
*
0.
02
0.
00
**
*
0.
20
0.
03
**
*
V
a
ri
a
n
ce
co
m
p
o
n
e
n
ts
–
p
a
ti
e
n
t
le
v
e
la
σ2 ε
,h
0.
03
0.
00
**
*
0.
03
0.
00
**
*
17
8.
57
4.
15
**
*
17
8.
59
4.
15
**
*
60
.1
5
1.
40
**
*
60
.2
1
1.
40
**
*
co
v(
ε h
,
ε c
)
0.
00
0.
00
–
0.
00
0.
00
0.
05
0.
10
0.
09
0.
08
–
0.
05
0.
06
–
0.
03
0.
05
σ2 ε
,c
0.
19
0.
00
**
*
0.
14
0.
00
**
*
0.
19
0.
00
**
*
0.
14
0.
00
**
*
0.
19
0.
00
**
*
0.
14
0.
00
**
*
n
37
72
37
72
37
72
37
72
37
72
37
72
a
Se
e
Ta
b
le
s
2
an
d
6
fo
r
de
sc
rip
tio
ns
of
al
lv
ar
ia
bl
es
.
Th
e
ta
bl
e
re
po
rt
s
es
tim
at
es
of
co
ef
ﬁ
ci
en
ts
an
d
va
ria
nc
e
co
m
po
ne
nt
s
w
ith
st
an
da
rd
er
ro
rs
in
br
ac
ke
ts
.
*p
<
0.
05
;
**
p
<
0.
01
;
**
*p
<
0.
00
1.
ANALYSIS
56
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1Groin hernia repair
Bivariate response models, as described in Methodology and statistical approach, failed to estimate for the
groin hernia repair model. This is because, after allowing for risk adjustment, there appears to be no
systematic hospital variation with respect to the EQ-5D utility scores or the EQ-VAS scores. To study the
effect of case-mix variables and hospital characteristics on costs and outcomes of treatment, we estimate
these equations in isolation, i.e. constrain any correlation between the two objectives to be zero. The
results of these univariate estimations for groin hernia repair are reported in Table 15.
We ﬁnd that patients reporting better pretreatment health also report higher post-treatment health,
independent of whether this is measured by the EQ-5D or EQ-VAS. Post-treatment health status is
negatively associated with the Charlson scores, the number of diagnoses and the area deprivation of the
patient’s residence.
Cost of treatment and LoS are positively associated with age, the number of diagnoses and when more
than one consultant provided care; however, they are negatively associated with the number of patients
treated at the hospital. Patients who report better pretreatment health generate lower costs and have
shorter stays in hospital.
The lack of systematic variation in health outcomes precludes benchmarking of relative hospital quality
performance for groin hernia patients. However, there does appear to be scope for improved control of
resource use as indicated by the positive values for σ2γ,c in both the cost of treatment and LoS equations.57
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Street et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
TA
B
LE
15
R
eg
re
ss
io
n
re
su
lt
s
–
g
ro
in
h
er
n
ia
re
p
ai
r
V
ar
ia
b
le
a
H
ea
lt
h
o
u
tc
o
m
e
R
es
o
u
rc
e
u
se
EQ
-5
D
EQ
-V
A
S
Lo
S
C
o
st
o
f
tr
ea
tm
en
t
β
SE
β
SE
β
SE
β
SE
co
ns
ta
nt
0.
60
0.
01
**
*
36
.8
6
1.
08
**
*
0.
04
0.
07
1.
48
0.
08
**
*
ag
e
–
0.
00
0.
00
–
0.
06
0.
01
**
*
0.
01
0.
00
**
*
0.
00
0.
00
**
*
m
al
e
0.
03
0.
01
**
*
0.
61
0.
49
–
0.
01
0.
03
0.
02
0.
02
w
ch
ar
ls
on
–
0.
02
0.
00
**
*
–
2.
47
0.
27
**
*
0.
03
0.
02
0.
03
0.
01
**
ad
d_
di
ag
no
se
s
–
0.
01
0.
00
**
*
–
0.
77
0.
10
**
*
0.
11
0.
01
**
*
0.
03
0.
00
**
*
de
pr
iv
at
io
n
–
0.
14
0.
02
**
*
–
9.
88
1.
25
**
*
0.
07
0.
09
0.
07
0.
05
m
ul
tie
pi
–
0.
00
0.
02
0.
32
1.
82
1.
65
0.
12
**
*
0.
44
0.
06
**
*
pr
e-
tr
ea
tm
en
t
he
al
th
st
at
us
0.
37
0.
01
**
*
0.
60
0.
01
**
*
–
0.
24
0.
04
**
*
–
0.
10
0.
02
**
*
H
RG
2
–
–
–
–
0.
25
0.
03
**
*
0.
09
0.
01
**
*
H
RG
3
–
–
–
–
0.
41
0.
06
**
*
0.
28
0.
03
**
*
H
RG
4
–
–
–
–
0.
57
0.
14
**
*
0.
43
0.
07
**
*
H
RG
5
–
–
–
–
0.
22
0.
14
–
0.
03
0.
07
H
RG
ot
he
r
–
–
–
–
0.
99
0.
07
**
*
0.
62
0.
04
**
*
vo
lu
m
e
–
0.
00
0.
00
0.
00
0.
00
–
0.
00
0.
00
–
0.
00
0.
00
*
te
ac
hi
ng
ho
sp
ita
l
0.
01
0.
00
0.
37
0.
34
0.
14
0.
05
**
*
0.
13
0.
12
V
a
ri
a
n
ce
co
m
p
o
n
e
n
ts
σ2 γ
0.
00
–
0.
00
–
0.
03
0.
00
**
*
0.
28
0.
03
**
*
σ2 ε
0.
03
0.
00
**
*
15
7.
24
2.
18
**
*
0.
66
0.
01
**
*
0.
17
0.
00
**
*
n
10
,3
89
10
,3
89
10
,3
89
10
,3
89
a
Se
e
Ta
b
le
s
2
an
d
6
fo
r
de
sc
rip
tio
ns
of
al
lv
ar
ia
bl
es
.
Th
e
ta
bl
e
re
po
rt
s
es
tim
at
es
of
co
ef
ﬁ
ci
en
ts
an
d
va
ria
nc
e
co
m
po
ne
nt
s
w
ith
st
an
da
rd
er
ro
rs
in
br
ac
ke
ts
.
*p
<
0.
05
;
**
p
<
0.
01
;
**
*p
<
0.
00
1.
ANALYSIS
58
NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1Performance assessment
Identifying better/worse than expected performers
Table 16 presents the number of hospitals that are identiﬁed as being statistically signiﬁcantly different
from what would be expected given the characteristics of the hospital and its patients. The columns
‘Health outcome’ and ‘Resource use’ under the heading ‘Assessment by objective’ present the number of
hospitals performing statistically signiﬁcantly differently from the risk-adjusted average on each of these
objectives when analysed in isolation. Results reported under the heading ‘Joint assessment of objectives’
reﬂect the joint performance of hospitals on both objectives. Accordingly, if a speciﬁc hospital performs
better than expected in terms of health outcome but not in terms of resource use, it will not be considered
a better than expected performer in terms of joint performance.
Three important results can be derived from Table 16. First, a greater number of better/worse than
expected hospitals, with respect to cost performance, are identiﬁed when resources are measured in terms
of cost of treatment rather than LoS. Similarly, more hospitals are classiﬁed as performing signiﬁcantly
differently from the average when using condition-speciﬁc measures of health outcome instead of the
generic EQ-5D or EQ-VAS. In both cases, this reﬂects the higher variability in unadjusted scores that carries
through to the risk-adjusted performance estimates. Second, while many hospitals achieve better/worse
results than expected on one of the two objectives, very few can be identiﬁed as performing well or badly
on both objectives simultaneously. Third, no hospitals are identiﬁed as either better or worse than
expected in terms of their performance when resource use and health outcomes are jointly assessed for
varicose vein surgery. Because of this (and the earlier ﬁnding of a lack of systematic variation in health
outcomes across hospitals for groin hernia patients), we focus on hip replacement and knee replacement
in illustrating joint performance and in the remaining discussion.
Figures 21 and 22 present scatterplots of the performance estimates in the two-dimensional performance
space for all six resource use and outcome measure combinations for hip replacement and knee
replacement. Each point represents a hospital and we present CrIs for only those hospitals that are
identiﬁed as better/worse than expected performers on both objectives simultaneously.59
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TABLE 16 Numbers of better/worse than expected performing hospitals
Assessment by objective
Health outcome Resource usea Joint assessment of objectives
Better
than
expected
Worse
than
expected Total
Better
than
expected
Worse
than
expected Total
Better
than
expected
Worse
than
expected Total
Hip replacement (142 hospitals)
Cost of treatment
EQ-5D
utility score
2 5 7 56 44 100 1 2 3
EQ-VAS
score
1 3 4 56 44 100 1 2 3
OHS 3 6 9 56 44 100 2 3 5
LoS
EQ-5D
utility score
2 5 7 29 24 53 1 3 4
EQ-VAS
score
0 3 3 29 23 52 0 2 2
OHS 4 6 10 29 24 53 1 4 5
Knee replacement (143 hospitals)
Cost of treatment
EQ-5D
utility score
1 6 7 66 36 102 1 3 4
EQ-VAS
score
2 4 6 66 36 102 1 2 3
OKS 6 5 11 67 36 103 4 2 6
LoS
EQ-5D
utility score
1 6 7 30 28 58 0 2 2
EQ-VAS
score
2 3 5 29 27 56 2 1 3
OKS 6 5 11 30 28 58 2 1 3
Groin hernia repair (146 hospitals)
Cost of
treatment
– – – 10 17 27 – – –
LoS – – – 10 17 27 – – –
Varicose vein surgery (130 hospitals)
Cost of treatment
EQ-5D
utility score
0 0 0 47 35 82 0 0 0
EQ-VAS
score
0 0 0 47 35 82 0 0 0
AVVQ
score
1 3 4 48 35 83 0 0 0
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TABLE 16 Numbers of better/worse than expected performing hospitals (continued )
Assessment by objective
Health outcome Resource usea Joint assessment of objectives
Better
than
expected
Worse
than
expected Total
Better
than
expected
Worse
than
expected Total
Better
than
expected
Worse
than
expected Total
LoS
EQ-5D
utility score
0 0 0 2 10 12 0 0 0
EQ-VAS
score
1 0 1 1 10 11 0 0 0
AVVQ
score
2 3 5 2 12 14 0 0 0
a ‘Better than expected’ refers to lower than expected resource use and vice versa.
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FIGURE 21 Joint cost and quality performance estimates – hip replacement. (a) LoS/EQ-5D index; (b) LoS/EQ-VAS;
(c) LoS/OHS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS; and (f) cost of treatment/OHS.
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FIGURE 21 Joint cost and quality performance estimates – hip replacement. (a) LoS/EQ-5D index; (b) LoS/EQ-VAS;
(c) LoS/OHS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS; and (f) cost of treatment/OHS.
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FIGURE 22 Joint cost and quality performance estimates – knee replacement. (a) LoS/EQ-5D index; (b) LoS/EQ-VAS;
(c) LoS/OKS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS; and (f) cost of treatment/OKS.
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FIGURE 22 Joint cost and quality performance estimates – knee replacement. (a) LoS/EQ-5D index; (b) LoS/EQ-VAS;
(c) LoS/OKS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS; and (f) cost of treatment/OKS.
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66The effect of risk adjustment
Figures 23 and 24 illustrate the impact that risk adjustment has on the conclusions to be drawn at hospital
level regarding the relationship between outcomes (plotted on the x-axis) and resource use (plotted on the
y-axis) for hip replacement (Figure 23) and knee replacement (Figure 24). The grey dots indicate each
hospital’s relative performance in terms of the average outcomes and resource use for its patients when no
risk adjustment is undertaken. The black crosses indicate each hospital’s relative performance after
accounting for the inﬂuence of patient and hospital characteristics.
The most noticeable impact is on the estimation of hospital effects on outcomes, regardless of the PROM
considered. The distribution of effects is substantially narrower when we adjust for patient case mix and
production constraints than when we do not risk adjust. In contrast, the estimates of hospital effects
relating to resource use show little sign of adjustment, as reﬂected in the approximately equal dispersion
of effects before and after adjustment for case mix and production constraints. For outcomes, this
suggests that not only is there an uneven distribution of patient case mix across hospitals but also that
observable characteristics explain a signiﬁcant amount of the variation that we observe in the unadjusted
measures. For resource use, the observable characteristics of patients do not explain a great deal of
observed variation. One reason for this may be that for outcomes, the before-and-after nature of data
collection provides a very good opportunity to identify variations among patients beyond that which is
systematically related to other observable characteristics, such as age. In other words, our ability to
risk-adjust is greatly improved by having information on pretreatment health status and the impact of this
is clear in the narrowing of the distribution. This does raise issues for the reliability of risk adjustment in
other, more traditional, areas of performance measurement, e.g. standardised mortality rates or
readmissions. Although the pretreatment PROM score was used as an explanatory variable in the
resource use equations and does indeed explain some of the variation in resource use, the impact of risk
adjustment is markedly less pronounced.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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FIGURE 23 Effect of risk adjustment on joint resource use and health outcome performance – hip replacement.
(a) LoS/EQ-5D index; (b) LoS/EQ-VAS; (c) LoS/OHS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS;
and (f) cost of treatment/OHS. (continued)
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FIGURE 23 Effect of risk adjustment on joint resource use and health outcome performance – hip replacement.
(a) LoS/EQ-5D index; (b) LoS/EQ-VAS; (c) LoS/OHS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS;
and (f) cost of treatment/OHS.
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FIGURE 24 Effect of risk adjustment on joint resource use and health outcome performance – knee replacement.
(a) LoS/EQ-5D index; (b) LoS/EQ-VAS; (c) LoS/OKS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS;
and (f) cost of treatment/OKS. (continued)
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FIGURE 24 Effect of risk adjustment on joint resource use and health outcome performance – knee replacement.
(a) LoS/EQ-5D index; (b) LoS/EQ-VAS; (c) LoS/OKS; (d) cost of treatment/EQ-5D index; (e) cost of treatment/EQ-VAS;
and (f) cost of treatment/OKS.
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The routine collection of PRO data is long overdue and this English exercise promises to be an importantcomponent of international efforts to improve health-care provision. In this project we set out to
(1) characterise variation in outcomes in ways that are intuitive to patients and consistent with the original
format of the questionnaire, thereby helping them select a preferred provider of care and (2) assess the
relationship between the cost and outcomes of the four elective procedures for which PROMs data are
collected and to determine the extent to which variations in outcome and cost ratios are due to
differences in hospital performance.
To meet the ﬁrst aim, we measure variability in hospital quality in hip replacement surgery, which
necessitated meeting a number of methodological issues. Most previous efforts have focused on ensuring
adequate risk adjustment; however, our paper focuses on three methodological issues that have received
less attention to date.
First, rather than focusing on an aggregate PROM score, we argue that it is both more accurate and more
informative to assess each of the PROM dimensions in their own right. Our approach does not require
assumptions to be made regarding how to aggregate across health dimensions and offers insight about
which dimensions are particularly affected by hospitals. We set out an analytical strategy to explore
patient- and hospital-level variation in categorical responses within and across dimensions of the EQ-5D.
We ﬁnd variation in performance to be more pronounced across the mobility and usual activities
dimensions. In contrast, the performance on the pain/discomfort, anxiety/depression and self-care
dimensions is less varied. These insights cannot be gained from the EQ-5D utility data and, furthermore,
we ﬁnd that performance on the utility scale correlates well only with the anxiety/depression and pain/
discomfort dimensions. Incidentally, these are the dimensions that receive the highest weighting in the UK
EQ-5D tariff.11 In contrast, the dimensions mobility, usual activities and self-care have relatively low weights
attached to them and variation in performance across hospitals remains undetected when analysing
aggregate EQ-5D data.
Second, policy interest is in assessing the change in patient-reported health status as a result of treatment.
There are various ways that this change can be measured and modelled. Our approach has been to model
both pre- and post-treatment health status as resulting from the same reporting process and to conduct
multilevel analysis with measurement points clustered in patients, which themselves are nested in hospitals.
We argue that this is the appropriate modelling strategy because it acknowledges the features of the
data-generating process, allows for patient heterogeneity, with respect to observed and unobserved
factors, and makes best use of the available information. The presented methodology is readily applicable
to other conditions for which the EQ-5D data are collected and can also, in principle, be extended to
other instruments.
Third, in recognition of the expectation that health outcome data are to be used by an audience unfamiliar
with the interpretation of complex statistical results (e.g. patients and their relatives, purchasers of care
and family doctors), we have suggested an intuitively appealing and accessible way of summarising the
differential impact that hospitals have on treatment outcomes. Our graphical representation indicates the
probability of reporting a given health outcome and shows how these probabilities vary across health
dimensions and hospital providers. Prospective patients who place greater weight on one or more
particular dimension may use this information to select a hospital that has a differentially greater impact
than its peers do. Health-care providers should engage in clinical audits to identify the reason for variation.
The primary limitation of our proposed approach is the increase in dimensionality of the decision problem
for patients. Where aggregated scores result in one estimate of hospital performance, our approach
generates ﬁve, potentially divergent, answers. In a recent study, Dijs-Elsinga et al.65 have shown that a
large group of patients favour simple data presentation and prefer one overall measure of hospital quality;71
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72however, many patients intend to use more detailed quality information when making decisions about
where to seek care in the future.65 The question then arises of how much information should be provided
for the different objectives for which performance information can be used (i.e. patient choice,
accountability, identiﬁcation of best practice) and who decides the relative weighting of each component
and objective.12,66 Our study does not intend to resolve this debate. Rather, we present a means of making
inferences about hospital quality and presenting results when health outcomes are assessed through the
EQ-5D instrument. How best to communicate such performance data requires careful consideration, to
ensure it can be effectively understood and used.
Our second aim has been to investigate the relationship between hospital-level measures of health
outcome and resource use after allowing for patient case mix and hospital caseload. We do this by
constructing multilevel health outcome and resource use equations using data from individual patients
treated for one of four elective procedures in the English NHS. By formulating the regression models
of resource use and outcomes as a system of equations estimated in a SUR framework, we are able to
gain additional insight into the correlation between unobserved factors that drive both resource use
and outcomes.
In keeping with the wider literature, we ﬁnd that the observed patient characteristics conform to a priori
expectations in the manner that they affect resource use and outcomes across all four conditions. As
expected, we ﬁnd signiﬁcant unexplained interpatient variation in resource utilisation and outcomes after
allowing for observed characteristics. We also ﬁnd that for all four conditions there is signiﬁcant
unexplained variation in resource use among hospitals, whether this is measured by cost of treatment or
LoS. There is also unexplained variation among hospitals in the health outcomes experienced by patients
having hip replacement, knee replacement or varicose vein surgery. These results suggest room for
improvement among hospitals in both their utilisation of resources and patient outcomes. In contrast,
there is no substantial variation among hospitals in outcomes for groin hernia patients, rendering the
information redundant for benchmarking hospital performance for these patients.
One of the novelties of this aspect of the work is the use of correlated error terms across equations at
patient and hospital levels. As expected, at the patient level we ﬁnd a negative correlation between
resource use and outcomes for hip replacement and knee replacement. This suggests that, despite the
detailed nature of the observed characteristics, including the pretreatment level of health, omitted factors
exist that drive both resource use and health improvement in opposite directions.
However, we ﬁnd no signiﬁcant general correlation between resource use and outcomes at hospital level
across all four conditions. Plots of the hospital-speciﬁc effects for both resource use and outcomes conﬁrm
this conclusion with, for many of the PROM and resource use combinations tested, the general mass of
points looking randomly distributed without any obvious systematic relationship. In the cases where we
identify a systematic relationship, this tends to be negative. This would suggest that overall there is scope
to improve technical efﬁciency in the provision of elective surgery. Some hospitals could achieve better
outcomes by learning from other, best practice hospitals, without increasing costs; similarly, other
providers could reduce costs without compromising, or even by improving, health outcomes.
Very few hospitals are identiﬁed as positive or negative outliers; however, there are a few instances of
high-cost or -quality hospitals that could potentially justify the extra average costs of their procedures by
noting that the outcomes reported by their patients are better than expected. Whether or not the gain in
health outcomes is worth the additional cost and is, therefore, optimal for the NHS {i.e. below a NICE-style
cost per quality-adjusted HES [QALY; (quality-adjusted life-year) threshold]} is difﬁcult to tell given the
absence of sufﬁcient follow-up data to calculate QALYs.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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1. Choice of instrument. The EQ-5D and condition-speciﬁc measures tend to broadly agree in that they
show the same general properties in terms of post-treatment improvements. However, the PRO
measures do not always identify the same number of hospitals as outliers. The EQ-VAS, in contrast,
shows counterintuitive results in terms of increased post-treatment distributions and an overall negative
change for groin hernia treatments. We believe that this implies that the EQ-VAS may be subject to
greater error than the other two measures. Given that the generic EQ-5D measure may be used across
conditions and produces results that are generally in accordance with the condition-speciﬁc measures,
and that the EQ-VAS seems a noisier generic measure with no greater sensitivity, we can ﬁnd little to
recommend the continued use of the EQ-VAS as a PROM. Indeed, since we commenced our study, the
Department of Health has decided that collection of EQ-VAS data is no longer required as part of the
PROM survey.
2. Presentation of PROMs information to prospective patients. Careful consideration should be
given to the way in which PROM information is presented to patients and other stakeholders. PROM
scores, such as utility scores represented by the EQ-5D index, are not readily understood, or easily
interpreted, by a non-technical audience. Instead, hospital providers and the NHS Information Centre
should work towards translating results into more intuitive metrics, such as percentages, and present
results on the same scale on which PROM responses are provided. Our graphical presentation of the
probability of reporting a speciﬁc post-treatment health status category is an example of how to
do this.
3. Incentivise providers to improve participation rates. We ﬁnd that, in our dataset, only 40.6% of
eligible hip replacement patients participate in the baseline survey and provided a complete EQ-5D
health proﬁle, with a further 8% dropping out of the subsequent survey (see Missing data). The best
solution to dealing with missing data is to improve response rates. This is happening. Hospitals are
increasing the proportion of patients who undertake the survey by making the data collection
procedures more effective.67 Further efforts are required to maintain this momentum and achieve
consistently high participation rates over time, thereby reducing the risk that inferences about
performance are based on incomplete and potentially unrepresentative data.
4. Learn from good practice and challenge poor performance. Our analysis sorts hospitals into four
quadrants according to their performance in relation to both their costs and outcomes, having
controlled for case mix and hospital characteristics. A handful of hospitals in the south-east quadrant
perform signiﬁcantly better than the national average and some hospitals in the north-west quadrant
perform signiﬁcantly worse than the national average. The question is what may drive their better
(or worse) performance in relation to the procedure in question. The reasons may be due to differences
in coding practices, working relationships, staff mix, theatre and ward layouts, organisational culture,
etc. None of these reasons are observable from routine data and identiﬁcation requires site visits and
qualitative study. Our analysis identiﬁes which of the English NHS hospitals merit a visit and what types
of activity the visit should focus on, such as those caring for patients having the particular procedure.
5. Measure and evaluate PROMs for other hospital conditions. The PROMs initiative focused initially
on the four common surgical procedures evaluated in this report. These represent only 1.6% of total
hospital activity. To gain a fuller picture of hospital performance, PROMs should be extended to other
areas of hospital activity. This should ﬁrst be rolled out to those conditions or procedures where existing
evidence suggests wide variation in costs and/or other measures of quality.
6. It may be unnecessary to introduce a PROMs premium/penalty for these procedures under
payment by results. The Department of Health has raised the possibility of making payments based
on PROMs, a suggestion which has met with some resistance.68 Our research suggests PROM-related
payments are probably a blunt instrument – only a handful of hospitals have signiﬁcantly better
(or worse) PROMs than the national average so, by implication, only a few would be affected by
differential rewards. Furthermore, for hip replacement or knee replacement, we found a negative
association between cost of treatment and outcome, so better performance with respect to outcomes73
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74does not seem to require higher resource inputs. For these procedures, mechanisms other than
pay-for-performance may be more effective at reducing variation in performance.Implications for researchSeveral issues remain that we have not addressed in this study that have implications for future research.
1. Improve methods to deal with missing data. The problem of missing data pervades all research.
Based on the full information contained in HES, we can identify those patients who have not
participated or were not included in the follow-up. Falsely assuming that any substantial number of
missing values are generated at random could lead to biased inferences from a non-representative
population,43,44 raising questions regarding the validity of the assessment. Efforts are currently being
made to identify the reason for non-response.69 Given that it will be impossible to eradicate completely
the problem of missing data, future research should be directed towards developing methods for
handling missing data in the speciﬁc setting discussed here. Current methods, such as standard multiple
imputation, may be a valuable starting point; however, these methods may not be directly transferable
to hierarchical and non-randomised settings, such as characterised by the PROMs data.
2. Collect data that characterise patient severity. In this study we have controlled for patient risk
factors that are deemed clinically relevant, assumed to be exogenous to the hospital and can be derived
from routine inpatient records. However, we do not claim that this set of control variables is exhaustive.
Health outcomes may be affected by non-randomly distributed and unobserved patient characteristics,
such as severity of the medical condition or health-related behaviour. However, a key strength of our
study is that we control for the pretreatment health status. We believe that the health status with
which the patient presents prior to treatment contains much information to mitigate any bias resulting
from unobserved severity, making our analysis more robust than otherwise possible. In many studies,
pretreatment health status is unobserved.
3. Evaluate hospital performance in the context of the broader health economy. Throughout this
study we have assumed that, after controlling for a wider array of patient characteristics, the remaining
variation in changes in reported health can be interpreted as a result of variation in hospital quality. This
is the common interpretation given to risk-adjusted outcome measures such as readmission or 30-day
mortality rates. But hospitals are but one part of the care pathway. For instance, procedures such as hip
replacement are generally followed by extensive physiotherapy and these services are often delivered
outside the hospital environment and variation in quality may not be attributable solely to the hospital
of inpatient care. Further work is required to ascertain what pathway-related care is provided
subsequent to hospital discharge and to establish the sensitivity of hospital quality assessments to
this provision.
4. Incorporate PROMs in the broader quality assurance framework. Further consideration should be
given to the role that PRO performance information can play in the existing quality assessment
framework. While measures of risk-adjusted mortality, readmission and adverse events have been
criticised for their limited granularity and sensitivity,70 one should not dismiss their ability to identify
high- and low-quality providers of care. Further research is required to establish the additional value of
outcome data for hospital quality assessments and contrast it to the costs of collection.
5. Investigate means of communicating information about variations in hospital PROM
performance to patients. PROMs are new measures that have the potential to help patients assess
hospital quality. For example, in contrast to mortality rates, PROMs do not have a straightforward and
well-understood interpretation.16 Further research is required into how best to ensure consistency
between the analytical approach and dissemination of results to a relevant audience. For example, our
suggested way of presenting cumulative proportions of EQ-5D dimensions merits qualitative research
into its acceptability and interpretability.
6. Evaluate the impact of the PROMs initiative on patient choice and provider behaviour. The
introduction of PROMs was motivated partly to inform patients about where to seek care and to
encourage hospitals to scrutinise and improve the quality of their care. Have these motivations beenNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1realised? The evidence is not yet available. A before-and-after longitudinal study that controls for other
contemporaneous inﬂuences would be required to isolate the impact of PROMs on patient and provider
behaviour. As more data become available, such a study should be feasible.
7. Measure and evaluate PROMs for chronic conditions. The PROMs initiative is being considered for
people suffering from long-term conditions such as asthma, diabetes mellitus and heart failure. This
presents novel methodological challenges because (1) the purpose of care may not be curative but
rather to arrest the speed of decline of the condition, (2) care is usually delivered over extended time
periods and (3) patients may receive multiple types of intervention delivered by different hospitals.
Research is required to address these challenges and to evaluate the impact of care on the health of
the large group of the population that lives with chronic conditions.75
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PROM dataset
The PROM dataset contains duplicate records for which the episode identiﬁer epikey is not unique,i.e. does not form a key. The extent of this problem is generally small but requires addressing. For
example, out of 33,210 hip replacement episodes that form part of our PROM dataset, 526 episodes do
not have a unique episode identiﬁer. We clean duplicate records using the following protocol:
l Remove duplicate records that have already been identiﬁed as duplicates by the data facilitator
Northgate/NHS Information Centre. The variable status takes a value of ‘duplicate’ for these records.
l Remove the record for which the difference between the date of the pretreatment questionnaire (from
PROMs) and the date of admission (from HES) is greater. Do not remove any records if information
about either the date of the pretreatment questionnaire or the date of admission is missing.
l Remove the record for which more essential ﬁelds are not recorded. For example, if the EQ-5D health
proﬁle is incomplete for one record, but not the other, retain the record with the full EQ-5D health
proﬁle recorded.
l If duplicate records remain, randomly remove all but one record.83
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HSR Protocol – project ref: 09/2000/47
Version: 250211 HSR Protocol
Date: 25 February 2011Combining routinely collected data and patient outcomes to
measure the outcome/cost ratios of hospital procedures
and identify variation across providersChief investigator: Professor Andrew Street
Aims/Objectives
We aim (i) to assess the relationship between the cost and patient-reported health outcomes of four
secondary care procedures (ii) to determine whether and the extent to which variations in the outcome/
cost ratios are due to differences in provider performance.Background
From April 2009 the English Department of Health (DH) have required all providers of NHS-funded care to
collect patient-reported outcome measures (PROMs) from all patients before and after receiving surgery in
the NHS for hip and knee problems, varicose veins and hernias.
PROMs are instruments that capture the patient’s own assessment of their health. By comparing these measures
of health through time, changes in health can be identiﬁed and used to better understand the effect of health
care. These data are valuable to compare provider performance and sharpen incentives to improve quality.
The legitimate use of PROMs as performance indicators relies on isolating the variation which is under the
hospital’s control, from that variation which is outside its control (e.g. the characteristics of the patients;
and services delivered either before admission or after discharge, which exert an effect on patient-reported
health). ‘Case-mix adjustment’ offers a partial solution, but there is a danger that PROMs run into
problems similar to those evident in using mortality rates as measures of hospital performance (Lilford
et al. 2004; Lilford & Pronovost 2010). Our research is designed to help assess whether PROMs can
provide robust measures of provider performance.Need
The NHS is likely to face increased pressure in reducing costs due to the current economic climate. In order
to achieve greater efﬁciency, decision makers need to consider the impact of potential cost reductions on
patient outcome. By combining a patient-reported quality dimension to cost data in a recognised
framework, these research outcomes will aid decision makers in making more informed and evidence
based decisions on cost-containment.
PROMs data are already being collected routinely for all patients who are undergoing one of four
procedures: hip and knee problems, varicose veins and hernias. The Department of Health intends to use
PROMs to measure and reward hospitals in relation to their performance in securing health outcomes. The
research to support these ambitions has not yet conducted – it is not known whether PROMs can provide
a robust measure of hospital performance. If the measure is not robust, hospitals may be inappropriately
rewarded or penalised, at the risk of adverse consequences for hospitals and their patients.85
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APPENDIX 2
86Methods
Setting
Our analysis includes everyone in England who has one of the four procedures in NHS and independent
sector providers during the 2009/10 ﬁnancial year.Design
We will be analysing patient-level data and using PROMs to assess the relative efﬁciency of hospitals in the
production of health. The research will require us to tackle three empirical challenges that further enhance
the study’s originality:
1. The econometric models we estimate recognise that the empirical distributions of costs and outcomes
are likely to be non-normal. This will require regression techniques that account for distributional
features but do not suffer from transformation biases so that we are able to explain differences
between providers in a meaningful metric.
2. We shall account for patient characteristics (risk adjustment) and for the clustering of patients within
providers. This requires estimation of multi-level multivariate models.
3. We shall use regression modelling to explore the inter-relationship between outcomes and costs. Our
models will explicitly attempt to disentangle the causes and effects. The key challenge is to measure the
inﬂuence of the provider on costs and outcomes and to explore reasons why this inﬂuence might vary.Data Collection
Our research utilises routinely collected patient-level data and does not require collection of new data. We
shall combine three unique datasets:
1. The 2009/10 Hospital Episodes Statistics, which contains detailed information about every patient
treated in NHS hospitals.
2. The RC data, containing disaggregated cost information provided by every NHS hospital. We have
devised a means of matching costs to the patient records in HES and demonstrated how the combined
HES and cost data can be used to identify which patient characteristics explain costs (Laudicella et al.
2010; Kristensen et al. 2010).
3. The PROMs data being collected for unilateral hip replacement, unilateral knee replacement, groin
hernia repair and varicose vein surgery prior to and shortly after treatment.Data Analysis
We are interested in whether PROMs data can be used to make secure inferences about hospital
performance. At the heart of the analysis will be a regression framework which we will extend in stages to
incorporate the additional complexity of the analysis. Our multivariate regression framework recognises the
clustering of patients within providers and the empirical, non-normal distribution of cost and outcomes.
We will start from the simplest descriptive model which is then extended to address the fundamental
questions about whether differences in costs and outcomes are functions of differing case mix and
whether additional spending yields better outcomes (and at what value). There are three main steps
to the analysis.
1. Produce descriptive ‘unadjusted’ provider-speciﬁc cost and outcome measures. Taking follow-up
outcomes and costs only we will produce ratios identifying the systematic differences across providers
without allowing for any other explanatory factors. This exercise will identify the range of total variation
and will be used as a comparator point for the following steps.
2. Produce risk-adjusted provider-speciﬁc cost and outcome measures. If, as likely, particular providers are
receiving disproportionate amounts of complex patients who may have both higher costs and poorer
outcomes then their unadjusted performance scores may be misleading. This second step will risk-adjust
the provider speciﬁc measures of performance by including the impact of the patient case mix on bothNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1follow-up outcomes and costs. These variables will be constructed from HES and baseline PROMs data.
We will compare these adjusted results with the unadjusted results. Speciﬁcally we look for signiﬁcant
changes in provider ratios and at the overall distribution of ratios to ask: does risk adjustment bring
provider performance closer together or does it highlight greater variation?
3. Identify whether cost above case-mix adjustment is a driver for improved outcomes or indicative of
inefﬁciency. We will address whether some providers may have additional costs that yield better
outcomes after allowing for any higher costs due to more complex patients i.e. the explanation that a
provider may have higher costs because it delivers higher beneﬁts. This step is probably the most
challenging methodologically as it requires that we fully disentangle the system of relationships
between patient characteristics, different types of costs (what is deemed due to patient characteristics
and what appears in excess) and outcomes. Again, we will compare results with unadjusted and
adjusted ratios and draw attention to any divergences across hospitals.Contribution to existing research
We have pioneered analysis of patient-level data to identify which patient characteristics drive costs and
whether costs are related to the hospital in which the patient is treated (Olsen and Street 2008; Laudicella
et al. 2009). We have been able to incorporate some indicators of patient outcome in these analyses,
including infections and 30-day mortality. PROMs provide a broader measure of outcome and promise to
offer deeper insight into why costs differ among patients. PROMs measure the patients’ own assessment
of their health. From April 2009 PROMs data have been collected from patients before and after receiving
surgery for hip and knee problems, varicose vein and hernias. The differences between patient-reported
health before and after surgery can be used to examine the effect of surgery; variations between providers
in changes in patient health also provide a basis for examining differences in hospital performance
(Browne et al. 2007; Devlin et al. 2009; Devlin and Appleby 2010).
Our research is set within a growing literature concerning the measurement of quality of care, the
relationship between quality and cost and the assessment of providers’ performance. Speciﬁcally, our
research builds on a collaborative project with Professor Nick Black at LSHTM. This utilises data generated
by the Patient Outcomes in Surgery (POIS) Audit and will provide an initial understanding of the nature of
the relationships between costs and outcomes, using a small dataset. We build on work to develop a risk
adjustment methodology for PROMs data currently being undertaken by Northgate & CHKS Ltd on behalf
of the Department of Health. This will ensure that our proposed research builds on sound foundations.Plan of Investigation
The main project tasks will be addressed in a sequential but overlapping manner, as depicted in the ﬂow
diagram. These are to (i) link and clean PROMs, HES and RC data; (ii) undertake descriptive analysis and
comparison of PROMs instruments; (iii) estimate risk adjustment models of outcomes and cost;
(iv) undertake joint estimation of outcome and costs; (v) estimate and analyse provider effects; and
(vi) undertake sensitivity analysis of provider effects to choice of instruments and modelling choices.
Project Management
Andrew Street will be responsible for the overall management and delivery of the project and Chris Bojke
will be responsible for the day to day management of the project. Nancy Devlin will provide leadership on
the analysis of the PROMS data and comparison of instruments. Silvio Daidone will be responsible for the
merging of data, data cleaning and advising on the econometric analysis. Nils Gutacker will be responsible
for data management and manipulation, and for execution of the econometric analyses, supervised on a
day-to-day basis by Chris Bojke.
The project team will hold video conferences every two weeks and we shall have quarterly face-to-face
meetings. All team members will contribute to formulating the econometric analysis, evaluating and
interpreting the emerging ﬁndings, writing the ﬁnal report, and disseminating the results. An advisory
group consisting of stakeholders from the DH, the EuroQol group and academic, clinical, professional and87
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DOI: 10.3310/hsdr02010 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 1lay communities will meet in London on three occasions during the 12 month course of the project: at
initiation and prior to delivery of the interim and ﬁnal reports.Service users/public involvement
We shall secure service user involvement, ﬁrstly, by including lay representation on the project’s advisory
group, which will give initial and ongoing overall guidance to the project. Secondly, we shall hold a
workshop to share our draft ﬁnal results with various interested parties, including representatives of the
service user community, such as patient choice advisors and existing lay members of the Royal College of
Surgeon’s or the BMA’s Patient Liaison Groups. This workshop will include presentations by the project
team followed by breakout sessions. Thirdly, we shall organise a 1-day conference at which we will
present the ﬁnal results of this project, alongside presentations on the general topic of PROMs by
other speakers.
As the results of our work are likely to impact on providers of care, we are particularly interested in the
views of acute NHS Trusts. We shall therefore aim to secure input from members of the NHS
Confederation and participants of the NHS Strategic Financial Leadership Programme, Executive Education,
Cass Business School, London.References© Qu
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